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Adolescence is a developmental period that coincides with increased exploration, social 
interaction, risk-taking, and novelty-seeking, as well as the symptomatic onset of psychiatric 
illnesses. Remodeling of the mesocorticolimbic and nigrostriatal dopamine systems has been 
implicated in these vulnerabilities. Yet, little is known about functional consequences of this 
remodeling. This dissertation sought to investigate the dynamics of dopamine neurotransmission 
in adolescent rats in two functionally distinct dopamine innervated striatal subregions: the 
nucleus accumbens (NAc), which is implicated in reward processing, and the dorsal striatum 
(DS), which is involved in habit formation and flexible learning.  
The psychostimulant amphetamine was used as a tool to activate dopamine release in 
behaving rats. Microdialysis was used to measure extracellular levels of dopamine. An acute 
systemic administration of amphetamine caused smaller amphetamine-induced dopamine efflux 
in the DS of adolescent rats (postnatal days 35-38) compared to adults. Dopamine in NAc was 
increased similarly in both age groups. Amphetamine also caused reduced levels of stereotypy 
behavior in adolescents than adults. Reduced effectiveness of amphetamine in DS was not due to 
age-related differences in the dopamine transporter (DAT). Though adolescents have lower 
levels of DAT in the NAc and DS than adults, the DAT inhibitor nomifensine similarly inhibited 
basal and amphetamine-induced dopamine efflux in both striatal subregions of both age groups. 
Furthermore, vesicular monoamine transporter-2 (VMAT2) expression was similar in the DS and 
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NAc of both adolescent and adult rats. In contrast, expression of tyrosine hydroxylase (TH) was 
reduced in the DS, but not the NAc, of adolescents compared to adults. The adolescent rats also 
were behaviorally more sensitive to the effects of a TH inhibitor. Together these data suggest 
that dopamine neurotransmission in the DS of adolescents is hypofunctional compared to adults, 
resulting in part from reduced TH activity. Given that actions of dopamine on striatal neurons are 
primarily inhibitory, functions associated with DS, such as action selection and habit formation, 
may be less responsive to dopamine meditated inhibition during adolescence. 
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1.0  INTRODUCTION 
Adolescence is considered to be a transitional period from childhood to adulthood, accompanied 
by changes in physical, psychological, and social development (Ernst et al., 2006), that will 
ultimately enable individuals to acquire necessary skills to become independent. These dramatic 
changes are thought to render adolescents as more prone to engage in deleterious behavior and 
have increased incidence of several psychiatric illnesses, making this developmental period a 
time of considerable vulnerability. Thus, understanding normal brain development throughout 
adolescence and adolescents’ increased risk for mental illnesses is an important public health 
issue to address. 
While the timing of puberty and adolescence overlap, these terms are not synonymous. 
Puberty, a period of sexual maturity, is defined by temporally discrete biological events (Falkner 
and Tanner, 1986; Pickles et al., 1998),whereas adolescence is considered a gradual maturation 
process of a series of “soft events” with no finite onset or offset (Pickles et al., 1998; Spear, 
2000). It is for these reasons that, in various mammalian species, there is a dispute amongst 
researchers on the exact age range of adolescence. Sex, for instance, can influence the 
adolescence time frame, as female mammals across species mature at a younger age than males 
(Falkner and Tanner, 1986). Human adolescence is typically considered to occur during ages 12 
to 18 years, though this developmental time span can include early- to mid- 20s (Baumrind, 
1987; Spear, 2000).  In rats, adolescence is generally accepted as postnatal days 28-49 (Spear 
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and Brake, 1983). Unlike other mammalian species, human adolescence is influenced not only 
by physiological changes, but also by sociocultural and economic conditions. Though these 
external factors make it difficult to define adolescence in animal models, researchers have been 
able to distinguish behaviorally and physiologically the adolescent time period apart from 
childhood and adulthood. Despite different research groups varying in how they classify their 
adolescent subjects based on age and level of development, for clarity’s sake the literature 
reviewed here typically defines adolescence as the teenage years for humans, two to four years of 
age for monkeys, and postnatal days 28 to 42 for rats. Also, the use of the term “juvenile” in the 
reviewed animal studies here typically refers to pre-adolescent animals.  
1.1 ADOLESCENT BEHAVIOR 
Part of the “soft events” that define the adolescent transitional phase between childhood and 
adulthood are characteristic behaviors shared across species. In general, these behaviors include 
increased social behavior (Csikszentmihalyi et al., 1977), increased novelty and sensation 
seeking (Adriani et al., 1998; Stansfield et al., 2004; Stansfield and Kirstein, 2006), increased 
risk taking (Steinberg, 2008), emotional instability (Steinberg, 2005), and impulsivity  (Adriani 
and Laviola, 2003; Chambers et al., 2003; Vaidya et al., 2004). In both rodents and humans, 
adolescents exhibit increased social interactions with peers (Csikszentmihalyi et al., 1977). The 
quality of these social interactions has also been shown to change in adolescence, for instance 
with peak levels in play behavior and reductions in aggressive behaviors (Pellis et al., 1992). 
Studies have also shown that adolescent rodents and humans make more impulsive choices in 
delay-discounting tasks, preferring smaller rewards occurring sooner over delayed larger rewards 
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(Adriani and Laviola, 2003; Steinberg et al., 2009). Sensation seeking, defined as the need for 
varied, novel sensations and experiences, is also seen in both rodents and humans. Adolescent 
rodents prefer novelty, exhibit greater novelty-induced locomotion, and spend more time 
exploring open arms in an elevated plus maze than adults (Laviola and Adriani, 1998; Douglas et 
al., 2003; Adriani et al., 2004; Stansfield and Kirstein, 2006). Similarly, human adolescents score 
higher on the Sensation-Seeking Scale than adults, with male adolescents scoring higher levels 
than females (Zuckerman et al., 1978). However, sensation seeking in humans tends to be 
greatest during early- to mid-adolescence, and declines in late adolescence to adult levels 
(Steinberg, 2008). Increased risk taking, and novelty and sensation seeking may serve as 
adaptive behaviors that allow adolescents to become more independent, to explore adult 
behavior, and to accomplish other normal developmental cognitive tasks, such as abstract 
reasoning (Silbereisen and Reitzle, 1992; Muuss and Porton, 1998; Spear, 2000). 
Unfortunately, risk taking in adolescents can also prove to be maladaptive. Human 
adolescents, relative to other age groups, are disproportionately more likely to exhibit reckless 
behavior, sensation seeking, and risk taking (Spear, 2000). Reckless behavior can be considered 
“normal behavior” when approximately half of all adolescents engage in drunk driving, sex 
without contraception, illegal drug use, and minor criminal activities (Spear, 2000). This 
recklessness often has negative consequences such as incarceration, AIDS infection, and 
unwanted pregnancy (Lerner and Galambos, 1998; Spear, 2000). Furthermore, adolescent 
morbidity and mortality rates are twice that of pre-pubescent children (Dahl, 2004). Increased 
novelty and sensation seeking during adolescence is also associated with increased drug and 
alcohol use. For instance, the escalation of cocaine use is higher in adolescent users compared to 
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adults (Estroff et al., 1989), and adolescents who become addicted to alcohol have rates of 
relapse similar to alcoholic adults, despite the shorter length of use (Brown, 1993). 
The likelihood of adolescent risk taking and recklessness calls into question how 
adolescents process risk at this age compared to individuals of other age groups. There is little 
evidence to suggest that adolescents perceive themselves as invulnerable or underestimate risk, 
but rather they tend to overestimate risk (de Bruin et al., 2007). In fact, an individual’s perceived 
risk of risky behavior has been shown to decline with age during adolescence (Irwin Jr, 1993). 
There are some arguments to suggest that adolescents may engage in risk taking in order to gain 
the positive arousal associated with sensations of novelty, complexity, change or intensity of 
experience (Zuckerman, 1992). Therefore, adolescents may require a higher level of risk taking 
in order to achieve the desired feeling or sensation from certain reinforcers. On the other hand, 
risk taking and sensation seeking may have little to do with the pursuit of positive outcomes from 
novel or rewarding stimuli, but rather be a result of an attempt to reduce dysphoria or a 
mechanism to cope with stress (McCord, 1990; Irwin Jr, 1993). Adolescent risk taking can thus 
be considered “an optimal life-span pattern for a rational decision maker who must gain 
knowledge of self and environment through experience” (Gardner, 1999). 
In addition to the vulnerability of adolescents when it comes to risk taking and “normal” 
behavioral development, the adolescent period is a time in which the symptoms of psychiatric 
illnesses, including mood disorders, eating disorders, addictive disorders, and schizophrenia, 
typically manifest (Weinberger, 1987; Volkmar, 1996; Pine et al., 2002; Chambers et al., 2003; 
Andersen and Teicher, 2008; Paus et al., 2008). In fact, previous data have indicated that the 
peak age of onset for any mental health disorder is 14 years (Kessler et al., 2005). It has been 
suggested that the emergence of these psychopathologies during this developmental time frame 
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may be due to aberrations of typical adolescent maturation processes combined with 
psychosocial factors and biological environmental factors (Paus et al., 2008). Furthermore, 
cognitive control, which continues to improve throughout adolescence, is often times 
compromised in these psychopathologies (Luna and Sweeney, 2004; Sweeney et al., 2004). The 
neuronal mechanisms that contribute to psychiatric illness vulnerability during adolescence, 
however, are not well understood (Thompson et al., 2004; Carlsson and Carlsson, 2006; Tseng et 
al., 2007; Davey et al., 2008; Nemoda et al., 2011). 
1.2 ADOLESCENT NEURODEVELOPMENT 
The typically developing adolescent brain undergoes many neural and gross morphological 
alterations. While the human brain reaches approximately 80 to 90% of its adult size during 
childhood (Dekaban, 1978), gray and white matter subcomponents of the brain continue to 
undergo dynamic changes throughout adolescence. Human neuroimaging studies have shown 
white matter volume increases linearly throughout childhood and adolescence, with maximum 
volumes reached in adulthood (Pfefferbaum et al., 1994; Gogtay et al., 2004). Diffusion tensor 
imaging studies suggest that increases in white matter volume may be an indication of the 
ongoing maturation of axons along with myelination by oligodendrocytes (Snook et al., 2005; 
Paus, 2010). Unlike white matter changes, the total volume of gray matter in the brain appears to 
increase prior to puberty with subsequent post-pubertal loss, resulting in an inverted U-shaped 
developmental trajectory in each lobe (Jernigan and Tallal, 1990; Jernigan et al., 1991; Giedd et 
al., 1999; Sowell et al., 2001). This maturation appears to occur in a “back-to-front” pattern, with 
primary sensorimotor areas maturing first, followed by association areas, and lastly higher-order 
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cortical areas (Huttenlocher, 1979; Gogtay et al., 2004). Nonhuman primate studies using 
electron microscopy have observed dramatic decreases in the number of synapses in cortical 
areas during adolescence (Rakic et al., 1986; Bourgeois and Rakic, 1993). Together these data 
suggest that synaptic pruning occurs in the human and nonhuman primate adolescent brain, and 
it is speculated that this pruning is an example of developmental plasticity as a way to 
accommodate environmental needs through experience (Rakic et al., 1994).  
In addition to cortical regions, subcortical areas, in particular the basal ganglia, change 
during adolescent development (Sowell et al., 1999). Gray matter reductions, for instance, have 
been observed in the striatum and other subcortical structures, following a similar U-shaped 
developmental trajectory seen in frontal and parietal cortical areas (Sowell et al., 2002). The 
developmental morphological changes in human subcortical structures such as the amygdala and 
hippocampus, however, are less well understood. One study observed amygdala volume 
increased signiﬁcantly during adolescence only in males and hippocampal volume increased only 
in females (Giedd et al., 1996).  
Studies of animal models of adolescence show that various neurotransmitter systems 
undergo significant developmental changes. For instance, rodent brain activity, as measured by 
glucose metabolism, oxygen utilization, and blood flow, reaches developmental peaks during 
adolescence, before declining in adulthood (Chugani et al., 1987). The adolescent brain also 
undergoes hippocampal neurogenesis (He and Crews, 2007), axonal growth (Benes et al., 2000), 
apoptosis (Markham et al., 2007) and myelination (Benes et al., 1994). Receptor overproduction 
and pruning has been observed in various neurotransmitter systems, such as dopamine, serotonin, 
acetylcholine, and endocannabinoid in the adolescent forebrain (Lidow et al., 1991; Lidow and 
Rakic, 1992; Rodriguez de Fonseca et al., 1993). During adolescence, axons and synapses in 
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select regions are overproduced, followed by rapid pruning later in adolescence (Crews et al., 
2007). These regions include limbic and cortical areas, such as dendritic pruning in the amygdala 
(Zehr et al., 2006) and prefrontal cortex (Andersen et al., 2000), with evidence suggesting that 
rodent limbic regions mature before prefrontal cortical areas (Teicher et al., 1995; Andersen et 
al., 2000).  
In contrast to synaptic receptor pruning, transporters for the monoamines dopamine and 
serotonin in the rodent dorsal striatum (DS) and nucleus accumbens (NAc) show increases in 
expression either prior to or during adolescence (Coulter et al., 1996; Tarazi et al., 1998b). 
Dopamine transporter (DAT) levels in both the DS and NAc are considered to follow a similar 
pattern of postnatal development, with higher DAT levels in adulthood compared to adolescence 
in these regions (Tarazi et al., 1998b). However, there have been other reports that show DAT 
levels peak in adolescence and gradually decline with age (Meng et al., 1999; Moll et al., 2000). 
Also, accumbal serotonin turnover is reported to be drastically lower in adolescent rats compared 
to both younger and more mature adult rats, while dopamine turnover and synthesis in the NAc 
and other striatal regions continues to increase throughout adolescence into adulthood (Andersen 
et al., 1997). Collectively, this remodeling is thought to be a form of developmental plasticity 
that allows adolescents to adapt to environmental needs in order to mature into adulthood (Crews 
et al., 2007).  
Among neurotransmitter systems, several lines of evidence indicate that the 
mesocorticolimbic and nigrostriatal dopamine systems undergo major remodeling during 
adolescence. Adolescent rodents have been shown to maintain lower basal extracellular levels of 
dopamine in the striatum than adults, while dopamine receptor overproduction and pruning in 
striatal regions has been observed (Gelbard et al., 1989; Andersen et al., 1997; Tarazi et al., 
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1998a; Badanich et al., 2006; Cao et al., 2007). Receptor overproduction and pruning of 
dopamine receptors (D1 and D2) is shown to occur in both human and rat (Spear, 2000). There is 
conflicting evidence, however, to support receptor pruning in both the NAc and DS. Several 
studies have found these regions reach peak levels of dopamine receptor binding in adolescence 
and then prune to adult levels (Gelbard et al., 1989; Teicher et al., 1995; Tarazi and Baldessarini, 
2000), while other studies suggest that dopamine receptor levels in the NAc and DS continue to 
increase throughout adolescence until reaching adult levels (Hartley and Seeman, 1983; Murrin 
and Zeng, 1986; Zeng et al., 1988; Leslie et al., 1991). 
In addition to structural changes of the dopamine system, the modulatory impact of 
dopamine receptor binding shifts from being mildly inhibitory to strongly excitatory during 
adolescence into early adulthood (O'Donnell, 2010). The functional consequences of dopamine 
receptor activation in the NAc and DS also vary depending on age, with adolescents exhibiting 
greater basal cAMP levels but lower D1 stimulatory and D2 inhibitory effects on adenyl cyclase 
production than adults (Spear, 2000). Firing rates of midbrain dopamine neurons have also been 
shown to peak during adolescence before decreasing over time into adulthood (McCutcheon and 
Marinelli, 2009). This developmental remodeling may lead to dynamic changes in the sensitivity 
of the dopamine system to external stimuli that may mediate some of the behavioral changes 
observed in adolescents. 
Along with the changes in the dopamine system, there are shifts in excitatory and 
inhibitory neurotransmission occurring in adolescence. The cortical binding of the excitatory 
neurotransmitter glutamate to its NMDA receptor subtype peaks in early adolescence and 
declines significantly thereafter into adulthood (Insel et al., 1990; Guilarte and McGlothan, 
1998). In the prefrontal cortex, the excitability of fast-spiking interneurons changes during 
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adolescence as demonstrated by reduced NMDA currents (Wang and Gao, 2009). In the NAc, 
studies have observed a reduction in accumbal NMDA receptors as well as the loss of excitatory 
glutamate input to NAc during adolescence (Frantz and Van Hartesveldt, 1999b, a). Levels of the 
inhibitory neurotransmitter GABA in the rat forebrain increase in a linear pattern throughout 
adolescence (Hedner et al., 1984). In monkeys, significant changes in both pre- and post-synaptic 
markers of GABA synapses occur in the prefrontal cortex during adolescence (Lewis et al., 
2004). Specifically, basal levels of GABAA receptor-mediated chloride current are greater in the 
adolescent cortex compared to adults (Kellogg et al., 1993b). Furthermore, the responsiveness of 
cortical GABAA neurotransmission to stressors decreases from adolescence to adulthood 
(Kellogg et al., 1993a; Kellogg, 1998). The modulatory impact of dopamine-receptor activity 
shifts during adolescence, such that activation of dopamine D2 receptors increases interneuron 
activity and dopamine D1 receptor activation leads to NMDA receptor changes (Wang and 
O'Donnell, 2001; Tseng and O'Donnell, 2007). 
There may be several important functional consequences of these developmental 
alterations and shifts in the balance of excitatory and inhibitory neurotransmission. For instance, 
adolescence is considered a highly plastic time of corticolimbic brain development, as evidenced 
by the fact that long-term potentiation, which is a form of plasticity measured by increases in 
synaptic strength, is more frequently found in the NAc of adolescent mice compared to adults 
(Schramm et al., 2002).  
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1.3 DOPAMINE NEUROTRANSMISSION 
Dopamine is a neuromodulator involved in the regulation of neuroendocrine secretion and 
various behaviors including learning (Wise, 2004), cognitive flexibility (Stefani and 
Moghaddam, 2006; Robbins and Roberts, 2007), reward perception (Schultz et al., 1997; 
Berridge and Robinson, 1998), and goal-directed movements (Beninger, 1983; LeMoal and 
Simon, 1991). There are four major dopaminergic pathways that have been identified in the 
mammalian brain originating from groups of dopamine-containing cells in the midbrain: the 
nigrostriatal pathway originating from A9 (substantia nigra pars compacta), the mesolimbic and 
mesocortical pathways originating from A10 (ventral tegmental area), and the tuberoinfundibular 
pathway originating from A8 (Dahlström and Fuxe, 1964). Each of these subgroups of dopamine 
neurons is anatomically and functionally distinct and innervates the pituitary gland and forebrain 
structures such as the prefrontal cortex, NAc, and DS (Carlsson et al., 1962).  
The NAc and the DS are core structures of the mammalian basal ganglia, a group of large 
subcortical nuclei, whose projection medium-sized spiny neurons make up the vast majority 
(95%) of the striatum’s neuronal cell population (Gerfen, 2004). The DS is the main input 
structure of the basal ganglia, and receives vast projections from cortical regions involved in 
sensory, motor, and cognitive processes (Voorn et al., 2004). The DS is largely innervated by 
dopamine neurons from the substantia nigra pars compacta (Gerfen et al., 1987). Dopamine 
signaling in the DS plays an important role in voluntary motor control (Joel and Weiner, 2000), 
as well as instrumental learning (Balleine et al., 2009). Both dopamine and endocannabinoid 
signaling in the DS have also been shown to be essential in transitioning from goal-directed 
behavior to automatic habitual behavior (Hilario et al., 2007; Ashby et al., 2010). The NAc, on 
the other hand, receives afferent projections from the amygdala (Kelley et al., 1982) and 
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prefrontal cortex (Powell and Leman, 1976), as well as dopamine innervations from the ventral 
tegmental area (Gerfen et al., 1987). The NAc is considered the interface between limbic and 
motor systems and is thought to be important in converting “motivation” to “action” (Mogenson 
et al., 1980; Morgane et al., 2005). The NAc is thought to play a key role in adolescent risk 
taking and sensation seeking (Ernst et al., 2006; Casey et al., 2008; Steinberg, 2008). Despite 
their distinct roles in various behaviors, the NAc and the DS share some functional overlap in 
cognitive function (Voorn et al., 2004), particularly in the context of reward-mediated behavior. 
For example, blocking the mesolimbic or nigrostriatal dopamine pathways can attenuate the 
reinforcing effects of various rewards (Wise, 2005). 
The physiological actions of dopamine are mediated by five distinct G protein-coupled 
receptors that are divided into two major groups: the D1-class dopamine receptors, consisting of 
D1 and D5 receptors, and the D2-class dopamine receptors, consisting of D2, D3, and D4 
receptors (Andersen et al., 1990; Niznik and Van Tol, 1992; Sibley et al., 1992; Civelli et al., 
1993). D1 dopamine receptors are highly expressed throughout the DS, NAc, substantia nigra, 
olfactory bulb, amygdala, and frontal cortex, and are also found in the hippocampus, cerebellum, 
thalamic areas, and hypothalamic regions (Fremeau et al., 1991; Weiner et al., 1991). Activation 
of D1 dopamine receptors in the striatum, which are exclusively expressed on the postsynaptic 
neurons and coupled to G-protein Gs (stimulatory), excite medium spiny neurons in the “direct” 
striatal output pathway (Surmeier et al., 2007). Conversely, the role of the D2 dopamine 
receptors is not as straightforward due to their expression both presynaptically and 
postsynaptically (Missale et al., 1998; Sibley, 1999). D2 dopamine receptors are highly 
expressed throughout the striatum and the olfactory tubercle (Bouthenet et al., 1991). 
Presynaptically localized D2 dopamine receptors, or autoreceptors, serve as an important 
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negative feedback mechanism that adjusts neuronal firing rate, synthesis, and release of 
dopamine in response to changes in extracellular dopamine levels (Wolf and Roth, 1990; Missale 
et al., 1998; Sibley, 1999). Therefore, activation of presynaptic D2 autoreceptors generally 
causes a decrease in dopamine release that results in decreased locomotor activity, whereas 
activation of postsynaptic receptors stimulates locomotor activity. 
Our understanding of the functional integrity of the NAc and DS is largely based on 
animal studies observing behavioral responses to dopaminergic drugs. Decreasing or depleting 
dopamine by blocking dopamine receptors or lesioning dopaminergic cells with 6-hydroxy-
dopamine (6-OHDA) reduces spontaneous locomotion, while drugs that enhance dopamine 
neurotransmission, such as the psychostimulants amphetamine and cocaine, produce 
hyperlocomotion and stereotypy (Beninger, 1983). Amphetamine disrupts DAT function, 
causing efflux of a newly synthesized, “releasable” pool of dopamine, as well as vesicular 
dopamine (Sulzer et al., 1995; Jones et al., 1998). There is a dorsal-ventral relationship in the 
striatum related to dopamine function in that stereotypy and fine movements are attributed to DS 
dopamine activation, whereas hyperlocomotion is attributed to dopamine activation in the NAc 
(Beninger, 1983; Delfs et al., 1990).  
Changes in response to dopamine altering drugs on striatal function are also apparent in 
more complex, conditioned behaviors. Infusing selective dopamine D1 or D2 receptor 
antagonists into the NAc has been shown to potently suppress locomotor responses associated 
with the motivational state of hunger (Baldo et al., 2002), and depleting dopamine using 6-
OHDA lesions in the NAc has been shown to suppress instrumental responding reinforced with 
food (Heffner and Seiden, 1983). Inactivating the DS using lidocaine, on the other hand, has 
been shown to block the ability of animals to shift behavioral control from goal-directed actions 
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to habits (Packard and McGaugh, 1996). Furthermore, local injections of amphetamine into the 
NAc, but not the DS, have been shown to potentiate conditioned reinforcement (Taylor and 
Robbins, 1984). 
1.4 DOPAMINE DYSFUNCTION AND ADOLESCENT VULNERABILITY 
Numerous studies have shown that adolescents exhibit different pharmacological sensitivity to 
drugs interacting with the mesocorticolimbic and nigrostriatal dopamine systems. Previous 
studies have shown that adolescent rats are less sensitive than both juvenile and adult animals to 
the locomotor activation of psychostimulant drugs such as cocaine and amphetamine (Spear and 
Brake, 1983; Bolanos et al., 1998; Laviola et al., 1999). Adolescents also show reduced 
amphetamine-induced taste aversion compared to juvenile and adult animals (Infurna and Spear, 
1979). Evidence suggests that this reduced sensitivity to amphetamine in adolescence is not due 
to age-related alteration in drug levels in the brain (Spear and Brake, 1983). Furthermore, rats 
exposed to low doses of the stimulant methylphenidate during adolescence have been shown to 
increase cocaine self-administration in adulthood, suggesting that early age stimulant exposure 
may lead to an increase in the incentive value of low reinforcers later in life (Brandon et al., 
2001). Repeated low-dose exposure to methylphenidate in adolescent rats has also been shown to 
differentially change ventral tegmental area dopamine neuronal activity, depending on the length 
of treatment withdrawal (Brandon et al., 2003). Conversely, adolescent rats have been shown to 
be more sensitive to the cataleptic behavioral effects of neuroleptics, such as the dopamine 
receptor antagonist haloperidol (Spear et al., 1980; Spear and Brake, 1983; Teicher et al., 1993). 
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In addition to motor behaviors, dopamine levels are highly responsive to salient stimuli 
with both appetitive and aversive valence. Several lines of work indicate that dopamine neurons 
and terminal release of dopamine are activated by rewarding stimuli (Wise, 2005; Schultz, 2007). 
Various food reward conditions also increase dopamine release in the NAc (Hernandez and 
Hoebel, 1988; Wilson et al., 1995; Cousins et al., 1999). In addition to reward sensitivity, the 
mesocorticolimbic and nigrostriatal dopamine systems are sensitive to stress. Glucocorticoid 
receptors can be found on dopaminergic neurons in the rodent ventral tegmental area and the 
substantia nigra, as well as the dopamine terminals of the NAc and prefrontal cortex (Harfstrand 
et al., 1986; Diorio et al., 1993). As such, elevations of corticosterone secretion due to stress 
leads to the activation of dopamine transmission, where corticosterone treatment causes increases 
in extracellular dopamine levels in the NAc and prefrontal cortex, and removing the adrenal 
glands leads to decreases in extracellular dopamine levels in these regions (Imperato, 1989; 
Piazza et al., 1996b; Piazza et al., 1996a). Additionally, rodent studies have shown that acute 
external stress increases dopamine release in regions that are involved in the modulation of 
reward, such as the prefrontal cortex, amygdala, NAc and DS  (Abercrombie et al., 1989; 
Imperato, 1989; Finlay and Zigmond, 1997; Inglis and Moghaddam, 1999), as well as increases 
in dopamine turnover in these regions (Deutch and Roth, 1990; Finlay and Zigmond, 1997).  
Thus, dopamine dysfunction has been implicated in abnormal processing of both stressful 
and rewarding stimuli. Although the reward system has not been traditionally implicated in the 
pathophysiology of schizophrenia, it has been the topic of several recent reports suggesting that 
abnormal functioning of the reward system may be critical for formation of context-inappropriate 
associations in schizophrenia patients and may predispose them to psychosis (Jensen et al., 
2008). The “dopamine hypothesis” of schizophrenia initially made the assertion that dopamine 
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dysfunction underlies the behavioral abnormalities of the disorder. This hypothesis is supported 
by evidence showing that anti-psychotic medications alleviate the psychotic (positive) symptoms 
of schizophrenia. Most clinically effective anti-psychotic treatments are dopamine receptor 
antagonists (Baldessarini and Tarazi, 1996), though these treatments are less effective on 
negative symptoms, which include anhedonia, social withdrawal, and affective flattening 
(Kirkpatrick et al., 2001). There have been imaging studies providing further evidence to support 
the dopamine hypothesis, where it has been reported that low doses of D-amphetamine cause 
increases in dopamine efflux in the brains of patients with schizophrenia compared to control 
subjects (Breier et al., 1997; Abi-Dargham et al., 1998; Laruelle et al., 1999). Depleting 
dopamine in the brain through the administration of the dopamine synthesis inhibitor alpha-
methyl-tyrosine in patients with schizophrenia revealed significant increases in dopamine D2 
receptors. This suggested that schizophrenics have higher levels of dopamine, causing increased 
occupancy of dopamine D2 receptors at baseline, which in turn obscured the difference in 
receptor densities that exists (Abi-Dargham et al., 2000). Furthermore, recent PET studies have 
suggested that patients with schizophrenia have elevated dopamine synthesis in the striatum, and 
that increased striatal dopamine levels in patients with prodromal symptoms of schizophrenia is 
correlated with the severity of prodromal psychopathologic and neuropsychological impairments 
(Howes et al., 2009; Nozaki et al., 2009). Overall, these studies suggest that the psychotic 
symptoms of schizophrenia are associated with increases in the synaptic release of dopamine, 
and these increased dopamine levels may cause sensitization to the actions of dopamine (Seeman 
et al., 2005). 
Dysfunction of the mesocorticolimbic and nigrostriatal dopamine systems has also been 
implicated in attention hyper deficit disorder (ADHD). In recent years, there has been an increase 
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in the use of dopamine-activating psychostimulants, such as amphetamine and methylphenidate 
(Ritalin1), to treat children and adolescents with ADHD (Shaywitz et al., 2001). 
Methylphenidate is a potent inhibitor of the DAT that potentiates the actions of synaptically 
released dopamine (Kuczenski and Segal, 1997; Volkow et al., 2001). Studies in rats have shown 
that therapeutic doses of methylphenidate, known to enhance cognition and reduce locomotor 
activity, actually increase dopamine in the prefrontal cortex (Berridge et al., 2006). Studies have 
also shown that increases in dopamine in the ventral striatum of adults diagnosed with ADHD 
were associated with reduced symptoms of inattention with clinical treatment of methylphenidate 
(Volkow et al., 2012). Moreover, D1 antagonists block the enhancing effects of methylphenidate, 
and therapeutic doses of methylphenidate have small effects on dopamine release in the NAc, 
which thereby cause therapeutic doses (taken orally) to have little abuse potential and suggests 
that they may be used to protect against drug abuse (Volkow et al., 2002; Svetlov et al., 2007). 
Imaging studies have suggested that an excess of DAT causes a hypodopaminergic state in 
patients with ADHD (Spencer et al., 2005), and elevated DAT levels have been reported in the 
striatum of ADHD patients compared to controls (Krause et al., 2000).  There are, however, 
other studies that refute these claims, providing data that show no differences in DAT (van Dyck 
et al., 2002) or decreases in DAT density in patients with ADHD (Jucaite et al., 2005). Lastly, in 
addition to studies of stimulant effects on patients with ADHD, there have been several genetic 
studies that have identified candidate risk factor genes, which include genes that encode the 
dopamine D4 and D5 receptors, and the dopamine and serotonin transporters (Bobb et al., 2005; 
Faraone et al., 2005).  
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1.5 USING AMPHETAMINE TO STUDY DOPAMINE RELEASE 
As has been mentioned in previous sections, amphetamine is often used experimentally to 
examine the function of dopamine and dopamine-modulated behaviors. However, amphetamine 
exerts diverse physiological and behavioral effects as a result of its mechanisms of action, and 
may be a useful for gaining further insight into the functions of various neurotransmitter systems 
and related.  
Amphetamine is a stimulant drug whose actions have been used for the treatment of 
disorders such as narcolepsy (Prinzmetal and Bloomberg, 1935), obesity (Ersner, 1940), and 
ADHD (Spencer et al., 1996). In fact, in the United States, amphetamine is the most commonly 
prescribed treatment for juvenile attention deficit disorder (Sulzer et al., 2005), though the 
mechanism for its efficacy is unclear but is thought to be due to the enhancement of tonic 
dopaminergic signaling (Knutson et al., 2004). Amphetamine’s use for treating obesity and 
narcolepsy arises from the fact that amphetamine has been shown to suppress food intake (Cole, 
1963) and has been used by the military to promote alertness, especially for long missions 
(Caldwell et al., 2003; Sulzer et al., 2005), respectively. Amphetamine has also been shown to 
have profound effects on numerous other behaviors such as aggression (Consolo et al., 1965; 
Welch and Welch, 1966), sexual behavior (Bignami, 1966), learning and memory (Bohdanecky 
and Jarvik, 1967; Carr and White, 1984), classical conditioning (Evangelista et al., 1970), and 
operant behavior (Clark and Steele, 1966; Laties and Weiss, 1966).  
Aside from its therapeutic uses, amphetamine is also a drug that leads to habitual use and 
abuse, due to it causing euphoria and stimulation in humans (Seiden et al., 1993).  The 
administration of large doses of amphetamine in humans has been shown to cause psychosis 
(Angrist et al., 1971; Ellinwood et al., 1973; Angrist et al., 1974). At low doses, amphetamine 
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increases hyperlocomotor activity and species-specific stereotypies at higher doses (Randrup et 
al., 1963). More specifically, in rats, low doses of amphetamine (1.0 mg/kg) induce locomotion, 
sniffing, and rearing, and at higher doses (5.0 mg/kg) induces focused intense licking and 
gnawing (Randrup et al., 1963; Scheel-Kruger, 1971; Gulley et al., 2004).  
The physiologic and behavioral effects of amphetamine were discovered to be due largely 
to amphetamine’s interaction with various catecholamine systems – such as dopamine and 
norepinephrine – in the brain and peripheral autonomic nervous system (Axelrod, 1972; Groves 
and Rebec, 1976). Amphetamine is thought to increase extracellular catecholamine 
concentrations by causing release from presynaptic nerve terminals in addition to inhibiting 
reuptake by blocking catecholamine uptake (Glowinski et al., 1966; Heikkila et al., 1975; 
Kuczenski, 1983; Seiden et al., 1993). The reuptake of catecholamines back into the nerve 
terminal is thought to be the primary mode of inactivation (Iversen, 1974). Amphetamine has 
also been shown to increase the release of serotonin and acetylcholine (Groves and Rebec, 1976; 
Pum et al., 2007). As such, drugs that affect serotonergic and cholinergic neurotransmission also 
affect amphetamine-induced locomotor responses and stereotypies (Armfred and Randrup, 1968; 
Weiner et al., 1973; Consolo et al., 1974; Goetz and Klawans, 1974; McGeer et al., 1974). The 
specific mechanisms of action of amphetamine are complex and somewhat controversial, but 
thought to involve the release, reuptake, and enzymatic inactivation of catecholamines (Seiden et 
al., 1993).  
Amphetamine is thought to increase dopamine levels through impulse-independent 
(calcium independent) transporter-mediated release, known as reverse transport (Sulzer et al., 
1995). Amphetamine is both able to cross plasma membranes via lipophilic diffusion, as well as 
serve as a substrate for catecholamine transporters (Liang and Rutledge, 1982; Zaczek et al., 
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1991a; Zaczek et al., 1991b; Seiden et al., 1993). Once inside the cells, amphetamine can 
displace dopamine from vesicles into the cytosol and be released through reverse transport by 
DAT (Sulzer and Rayport, 1990; Floor and Meng, 1996). Amphetamine’s action through 
vesicular depletion and reverse transport are controversial in the literature, and different models 
have been proposed to explain amphetamine-induced dopamine release. For instance, the 
exchange diffusion model suggests that as amphetamine is transported into the cell down its 
concentration gradient, it accelerates the efflux dopamine out of the cell down its concentration 
gradient (Fischer and Cho, 1979). Once dopamine has been transported out, the high 
concentration of amphetamine prevents the reuptake of dopamine (Fischer and Cho, 1979). As a 
substrate, amphetamine increases the number of inward-facing transporter binding sites, 
increasing the rate of reverse transport. In contrast, the weak base model suggests that 
amphetamines redistribute dopamine from synaptic vesicles to the cytosol by collapsing the 
vesicular pH gradient, decreasing the energy that supports neurotransmitter accumulation, 
thereby increasing the availability of the catecholamine for reverse transport without requiring a 
mobile site on the transporter (Sulzer and Rayport, 1990; Sulzer et al., 1993). Vesicular 
dopamine redistributed to the cytosol, in turn, can be rapidly released by reverse transport.  
Amphetamine-induced release of dopamine can be blocked by uptake inhibitors such as 
nomifensine (Raiteri et al., 1979), while blocking impulse-dependent release via action potentials 
with the drug tetrodotoxin, has no effect on increases in extracellular dopamine induced by 
amphetamine (Nomikos et al., 1990). These previous studies support the notion that 
amphetamine is a dopamine releaser that acts independent of cell firing. Moreover, 
amphetamine-induced behaviors are inhibited by blocking dopamine synthesis with the tyrosine 
hydroxylase (TH) inhibitor, alpha-methyl-para-tyrosine, but not by reserpine, which blocks 
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transport of amines into vesicles, suggesting the effects of amphetamine are mediated by a newly 
synthesized pool of dopamine in the cytoplasm (Randrup et al., 1963; Scheel-Kruger, 1971; 
Braestrup, 1977). To this effect, low doses of amphetamine are thought to release cytoplasmic 
stores of dopamine while higher doses of amphetamine are thought to release both cytoplasmic 
and vesicular pools of dopamine (Liang and Rutledge, 1982; Zetterstrom et al., 1986).  
Though amphetamine has been widely used to understand dopamine function in adults 
(as noted above), little is known about the impact of amphetamine on dopamine 
neurotransmission in adolescence. Previous studies have shown that adolescent rodents exhibit 
smaller behavioral activation (such as locomotion) in response to stimulant drugs compared to 
adults (Bolanos et al., 1998; Laviola et al., 1999). These findings suggest that dopamine, which 
mediates locomotor activity and stereotypies, may be differently regulated in adolescent and 
adults rats, and amphetamine may be a useful tool for investigating these developmental 
differences. 
1.6 PURPOSE OF DISSERTATION 
Previous studies show that the mesocorticolimbic and nigrostriatal dopamine systems undergo 
major developmental changes during adolescence. We believe these changes in adolescents may 
be differently modulated in striatal subregions compared to adults. Remodeling of the 
mesocorticolimbic and nigrostriatal dopamine systems in the striatum during the adolescent 
period has been implicated in the symptomatic onset of many psychiatric illnesses, including 
schizophrenia and drug addiction. The neuronal mechanisms that contribute to such vulnerability 
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during adolescence are not well understood and little is known about the dynamics of the 
dopamine system in behaviorally relevant contexts during adolescence. 
The purpose of this dissertation was to use a rodent model to gain a better understanding 
of the function of dopamine neurotransmission during adolescence by characterizing the 
mechanisms that regulate dopamine in two functionally distinct striatal subregions that are 
heavily innervated by midbrain dopaminergic cells, the NAc and the DS. These regions are 
integral to behaviors that are highly relevant to adolescent vulnerability to psychiatric illnesses. 
We utilized microdialysis to measure extracellular dopamine levels in the NAc and the DS in 
awake adolescent and adult rats while simultaneously measuring locomotor and stereotypical 
motor behaviors. The psychostimulant amphetamine was used to examine the mechanisms of 
dopamine release since this drug is known to cause increases in extracellular dopamine by 
disrupting the function of DAT, important for dopamine reuptake, and has also been shown to 
have differential behavioral effects in adolescence and adulthood in rodents.  
Upon discovering region-specific differences in dopamine neurotransmission in response 
to amphetamine administration in adolescents compared to adults (Chapter 2), we sought to 
further elucidate the mechanisms behind these differences, by examining the protein density and 
function of dopamine transporters – DAT and the vesicular monoamine transporter-2 (VMAT2) 
– involved in dopamine reuptake and packaging (Chapter 3), as well as protein expression and 
function of the rate limiting enzyme involved in dopamine synthesis – TH (Chapter 4). To 
examine the density of these specific dopamine-related proteins, we used Western blot analysis 
to measure protein expression levels. Function of DAT was assessed using the DAT-specific 
blocker nomifensine, which was infused directly into the NAc and the DS. To assess function of 
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TH, the TH blocker alpha-methyl-DL-tyrosine was administered systemically while assessing 
amphetamine-induced behavior. 
In Chapter 5, these mechanisms of dopamine availability are revisited in the context of 
the findings from this dissertation, and a hypothesis of reduced dopamine neurotransmission in 
the adolescent DS as a mechanism for adolescent vulnerability to psychiatric illness is 
introduced, along with suggestions for future work that might further delineate the mechanisms 
of adolescent behavioral and psychiatric risks. 
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2.0  THE EFFCTS OF AMPHETAMINE ON BEHAVIOR AND STRIATAL 
DOPAMINE NEUROTRANSMISSION IN ADOLESCENT AND ADULT RATS 
2.1 INTRODUCTION 
Adolescence is a transitional period from childhood to adulthood, which overlaps with puberty 
(Pickles et al., 1998). During adolescence, the brain undergoes major remodeling (Huttenlocher, 
1984; Rakic et al., 1994; Andersen et al., 2000), which may account for the behavioral changes 
associated with this developmental period. These characteristic behavioral changes include 
increased exploration, social interaction, risk-taking, and sensation- and novelty-seeking 
(Baumrind, 1987; Primus and Kellogg, 1989; Adriani et al., 1998). These behaviors, albeit a 
component of normal maturation processes, can have negative consequences that lead to 
increased injuries and mortality rates (Lerner and Galambos, 1998; Spear, 2000). Furthermore, it 
is during adolescence that the symptomatic onset of many psychiatric illnesses, such as 
schizophrenia, occur (Weinberger, 1987). The neuronal mechanisms that contribute to 
psychiatric illness vulnerability during adolescence are not well understood, although the 
dopamine system has been implicated (Thompson et al., 2004; Carlsson and Carlsson, 2006; 
Tseng et al., 2007; Davey et al., 2008; Nemoda et al., 2011).  
Dopamine neurotransmission plays a central role in modulating learning, stress reactivity, 
cognition, goal-directed behaviors, and reward processing (Robbins, 1997; Goldman-Rakic, 
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1998; Kelley, 2004a; Wise, 2005). Dysfunction of the mesocorticolimbic and nigrostriatal 
dopamine systems has been associated with schizophrenia (Carlsson and Carlsson, 2006), mood 
(Schildkraut, 1965) and addictive disorders (Koob, 1992), symptoms of which are manifested 
during early or late adolescence (Weinberger, 1987; Volkmar, 1996; Pine et al., 2002; Carlson 
and Meyer, 2006). The mesocorticolimbic and nigrostriatal dopamine systems experience 
significant remodeling during adolescence (Kelley et al., 2004; Fareri et al., 2008). These include 
changes in dopamine turnover, synthesis, and reuptake (Teicher et al., 1993; Andersen et al., 
1997). 
The purpose of the present study was to gain a better understanding of the dynamics of 
dopamine neurotransmission in behaving adolescents using a rodent model. We focused on two 
functionally distinct striatal subregions that are heavily innervated by midbrain dopaminergic 
cells: the nucleus accumbens (NAc) and the dorsal striatum (DS). These regions are integral to 
behaviors that are highly relevant to adolescent vulnerability to psychiatric illnesses. The NAc is 
implicated in motivation and reward processing (Mogenson et al., 1980; Robbins and Everitt, 
1996; Kelley, 2004b), and the DS is involved in learning, action selection, and habit formation 
(Yin et al., 2006; Yin and Knowlton, 2006; Balleine et al., 2009). Recent studies have described 
age related differences in the reactivity of neurons in these two regions to salient events 
(Sturman and Moghaddam, 2011a). We used amphetamine as a tool to activate dopamine release 
in the NAc and the DS in behaving adolescent and adult rats. Amphetamine disrupts the function 
of the dopamine transporter (DAT), causing efflux of vesicular dopamine and newly synthesized 
dopamine (Sulzer et al., 1995; Jones et al., 1998). Amphetamine-like stimulants are commonly 
prescribed to human youths with disorders such as ADHD for therapeutic use (Kutcher et al., 
2004), though little is known about their impact on dopamine neurotransmission at this age. 
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These stimulants produce smaller behavioral activation in adolescent rodents compared to adults 
(Bolanos et al., 1998; Laviola et al., 1999). Behaviors such as locomotor activity and stereotypy 
are dependent on the functional integrity of NAc and DS dopamine, and can be used as an 
indirect measure of the functional consequences of increased dopamine neurotransmission. Thus, 
examining the impact of amphetamine may be important for revealing developmental differences 
on some of the basic mechanisms that govern dopamine release in behaviorally active animals. 
This experiment will also generate relevant correlations between dopamine release alterations in 
response to amphetamine and dopamine-mediated behavioral changes in adolescent and adult 
rats.  
2.2 METHODS 
2.2.1 Subjects 
Male Sprague-Dawley rats (Harlan, Frederick, MD) were used for this experiment. Pre-
adolescent juvenile rats (postnatal days 21) and adults (postnatal days 60-70) were received at 
least two weeks prior to experimentation. This two week period allowed animals to habituate to 
the housing, and during this time juvenile rats reached adolescence. By the time of 
experimentation, adolescent rats used were considered between postnatal days 34-38 (~130-150 
g) and mature adults between postnatal days 70-80 (~ 330-400 g). All subjects were pair housed 
in a 12 hr light/dark cycle (lights on at 19:00).  Experiments were conducted during the animals’ 
dark (active) phase. Animals had ad libitum access to water and rat chow. All animal 
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experiments were performed in accordance with and approval by the ethical guidelines of the 
Institutional Animal Care and Use Committee at the University of Pittsburgh. 
 
2.2.2 Surgical Procedure 
All surgical procedures were performed between the hours 08:00 and 10:00. For microdialysis 
probe implantation, rats were anesthetized with isoflurane, placed on a heating pad, and had their 
heads secured in a stereotaxic apparatus using blunt ear bars. A small incision was made in the 
skin over the skull and the area irrigated with lidocaine. Animals were implanted bilaterally with 
dialysis probes, with one probe in the DS (for adolescents: AP +0.7 from bregma, ML +2.0 from 
bregma, and DV –5.0 from skull; and for adults: AP +1.6, ML +2.2, DV –6.0 from skull) and 
one in the NAc (for adolescents: AP +1.0 from bregma, ML +1.2 from bregma, and DV –7.0 
from skull; and for adults: AP +1.2, ML +1.1, DV –8.4 from skull). Coordinates for the dialysis 
probes were according to the atlas of Paxinos and Watson (Paxinos and Watson, 1998). Dialysis 
probes were constructed of Hospal AN69 polyacrylonitrile dialysis tubing (Renal Care, 
Lakewood, CO), with an outer diameter of 330 µm and an exposed tip of 1.0 mm for adolescent 
rats and 2.0 mm for adult rats. The smaller exposed tip for adolescents was used to account for 
smaller brain size at this age. Dialysis probes were secured in a head cap consisting of dental 
acrylic and were fastened to the skull using two skull screws. Immediately following surgery, the 
probes were connected to a liquid swivel balance arm assembly, and the rats were singly housed 
in a clear polycarbonate cage with fresh bedding. The cages were situated in a temperature and 
humidity controlled room on the same light/dark schedule (lights on at 19:00) used in the 
vivarium. Probes were connected to the liquid swivel balance arm assembly and the dialysis 
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probes were perfused at a rate of 1.5 µL/min with a Ringer’s solution (in mM: 145 NaCl, 2.7 
KCl, 1.0 MgCl2, and 1.2 CaCl2). Rats were given approximately 24 hr to recover from the 
surgery prior to the collection of microdialysis samples. This recovery time is accepted as a 
sufficient period of time for brain tissue to normalize after probe implantation (Krebs-Kraft et al., 
2007). A 24 hr recovery period is also a sufficient period of time for the overall health of the 
animals to return to normal, as our laboratory has shown previously (Moghaddam and Gruen, 
1991; Moghaddam and Bunney, 1993; Jedema and Moghaddam, 1994; Moghaddam and 
Bolinao, 1994). As such, animals used in the study did not show obvious signs of post-surgery 
distress, but instead groomed normally, ate food and drank water, and had no signs of bleeding 
or infection around the wound or head cap. Rats had ad libitum access to food and water during 
recovery, but not during the experiment.  
2.2.3 Microdialysis 
On the day of the experiment, rats remained in their home-cage for collection of samples (and 
behavioral testing). Probes were perfused with Ringer's solution only (as above) at a flow rate of 
2.0 μL/min during sample collection. Dialysis experiments started between 09:00 and 11:00. 
Dialysate samples were collected every 20 min for the duration of each experiment and 
immediately injected into a high-performance liquid chromatography system with 
electrochemical detection for the analysis of dopamine, with a detection limit of approximately 5 
fmol, as described previously (Adams and Moghaddam, 1998). At least 100 min of baseline 
samples were collected before pharmacological manipulation. Implanted animals were used only 
once for experimentation. In cases where there were technical issues with one of the two 
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bilaterally implanted probes, data from the working probe (and the corresponding behavior data) 
were included in the analysis. 
2.2.4 Behavior 
As mentioned above, rats remained in their home-cage for the collection behavioral data (and 
sample collection). Motor behavior during the microdialysis experiments was quantified as 
described before (Pehrson and Moghaddam, 2010). Briefly, stainless-steel frames with an array 
of 32 infrared beams arranged in a 16 x 16 formation around the outside of the animals’ cages 
(Hamilton-Kinder, LLC, Poway, CA). For experiments, beam breaks were monitored over the 
entire course of sample collection by the Kinder Scientific MotorMonitor program. Ambulations 
(locomotor movements) were defined as movements in which the animal moved its entire body 
(i.e., a new beam was broken while a previously broken beam was released) and fine movements 
(stereotyped movements) were defined as smaller movements where a new beam is broken 
without releasing a previously broken beam. Motor activity data were pooled into 20 min bins, 
corresponding to the collection of dialysis samples, and expressed in terms of the number of XY-
axis ambulations and fine movements.  
2.2.5 Drugs 
Once a stable dopamine baseline was reached, animals were given a systemic (i.p.) 
administration of 0.9% saline (1 ml/kg) or amphetamine (1.0 mg/kg; Sigma-Aldrich). 
Amphetamine was dissolved in 0.9% saline and frozen for a maximum of 1 week prior to use.  
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The dose of amphetamine used in this study was chosen based on previous studies that 
demonstrate that low doses of amphetamine (between 0.5 and 1.5 mg/kg) increase locomotion 
and some stereotyped movements (i.e. sniffing) in both adolescents and adults (Bolanos et al., 
1998; Gulley et al., 2004).  
2.2.6 Histology 
After completion of microdialysis experiments, rats were anesthetized with chloral hydrate (400 
mg/kg) and perfused intracardially with 0.9% saline. Brains were removed and stored in a 10% 
Formalin solution. Serial coronal 250 µm sections were taken through the regions of interest and 
then mounted on glass slides and stained with cresyl violet. Stained sections were then evaluated 
for accuracy of probe placement. Only data from placements within the brain region of interest 
were used for further analysis (Figure 2-1). 
2.2.7 Data analysis 
Microdialysis and behavior data were analyzed as described previously (Adams and 
Moghaddam, 1998; Pehrson and Moghaddam, 2010). The microdialysis data were expressed as a 
percentage of baseline dopamine efflux (mean ± sem), where baseline was defined as mean of 
the three baseline values obtained immediately before a pharmacological manipulation. Baseline 
means, reported as fmol/ul, for each group were analyzed using student t-tests. Locomotor 
activity and stereotypy data were separately expressed as the number of infrared beam breaks 
within a 20 min bin, to correspond with the 20 min microdialysis sample collection bins (mean ± 
sem). Statistical analysis of these dependent measures was conducted using two-factor repeated 
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measures ANOVAs, both with age or drug treatment as the between-subjects factors and time as 
the within-subjects factor. Significance was set at p < 0.05. Five-eight subjects per group were 
required based on an estimated effect size (considering previous work in our laboratory). All 
animals used for dopamine analysis in either the NAc or the DS or were combined for the 
behavior analysis. 
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Figure 2-1 Microdialysis probe placements 
Microdialysis probe placement for rats included in the study. Probes were placed bilaterally in the NAc and DS of 
adolescent and adult rats. Black bars represent the approximate location of probe placements, overlaid on standard 
adult rat atlas images (Paxinos and Watson, 1998). The size of the black bars represents the approximate size of the 
exposed dialysis tip: 1.0 mm for adolescents, 2.0 mm for adults. Numbers represent distance (in millimeters) 
anterior to bregma for adult animals.  
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2.3 RESULTS 
2.3.1 Dopamine Efflux 
The baseline mean (in fmol/μl) for the NAc was 0.48 ± 0.10 in adolescents (n = 10) and 0.60 ± 
0.14 in adults (n = 11), with no significant difference between age groups (t19 = -0.693, n.s.). The 
baseline mean (in fmol/μl) for the DS was 1.13 ± 0.33 in adolescents (n = 11) and 0.95 ± 0.29 in 
adults (n = 12), with no significant difference between age groups (t21 = 0.687, n.s.). Dopamine 
efflux was measured in adolescent and adult rats in response to systemic amphetamine (1.0 
mg/kg, i.p.). Amphetamine caused significant increases in NAc dopamine levels compared to 
saline controls in both adolescent (treatment × age, F(11, 88)=8.267, p < 0.0001) and adult 
(treatment × age, F(11, 99) = 22.16, p < 0.0001) rats (Figure 2-2A). Amphetamine also caused 
significant increases in the DS dopamine levels compared to saline controls in both adolescent 
(treatment × age, F(11, 110) = 5.646, p < 0.0001) and adult (treatment × age, F(11, 88) = 36.70, 
p < 0.0001) rats. Amphetamine had similar effects on increases in dopamine efflux across age 
groups in the NAc (time × age interaction, F(11, 110) = 1.25, n.s.) (Figure 2-2A). However, 
amphetamine increased dopamine levels significantly less in the DS of adolescent rats versus 
adults (time × age interaction, F(11, 99) = 27.30, p < 0.001) (Figure 2-2B). In control animals, 
the saline vehicle injection had no significant effect on dopamine efflux in either the NAc (time 
× age interaction, F(11, 77) = 0.811, n.s.) (Figure 2-2A) or the DS (time × age interaction, F(11, 
88) = 0.64, n.s.) (Figure 2-2D) of either age group.  
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2.3.2 Behavior 
Age-related behavioral differences were also measured simultaneously in animals used for 
microdialysis analysis in response to amphetamine. Systemic amphetamine administration 
caused significant increases in locomotor behavior in adolescent (treatment × age, F(11, 165) = 
1.97, p < 0.05) and adult (treatment × age, F(11, 132) = 5.79, p < 0.0001) rats compared to saline 
controls (Figure 2-2C). Amphetamine also produced increased levels of stereotypies in both 
adolescents (treatment × age, F(11, 165) = 3.59, p < 0.0001) and adults (treatment × age, F(11, 
132) = 5.19, p < 0.0001) compared to saline controls. Amphetamine produced similar changes in 
locomotor behavior in adolescents and adults (time × age interaction, F(11, 77) = 0.29, n.s.) 
(Figure 2-2C). However, amphetamine caused lower increases in fine motor movements (time × 
age interaction, F(11, 66) = 3.40, p=0.001) (Figure 2-2D) in adolescents compared to adults. 
Administration of the saline vehicle in control animals showed no effect on either locomotion 
(time × age interaction, F(11, 77) = 1.65, n.s.) (Figure 2-2C) or fine movements between groups 
(time × age interaction, F(11, 88) = 1.68, n.s.) (Figure 2-2D), though adolescent rats had a 
transient response in fine movements right after the injection. 
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Figure 2-2 Dopamine efflux and behavior in response to amphetamine 
Amphetamine caused lower increases in DS dopamine and fine movements in adolescent rats compared to adults. 
Adolescent (orange) and adult (blue) rats were given an i.p. injection of 1.0 mg/kg amphetamine (squares) or 0.9% 
saline vehicle (circles). Dopamine efflux was measured in the A) NAc (adolescent amphetamine group, n=6; adult 
amphetamine group, n=6; adolescent vehicle group, n=5; adult vehicle group, n=5) and B) DS (adolescent 
amphetamine group, n=6; adult amphetamine group, n=5; adolescent vehicle group, n=6; adult vehicle group, n=5). 
Motor behavior was also measured for each animal, expressed as C) ambulations (adolescent amphetamine group, 
n=8; adult amphetamine group, n=6; adolescent vehicle group, n=9; adult vehicle group, n=9) and D) fine 
movements (adolescent amphetamine group, n=8; adult amphetamine group, n=6; adolescent vehicle group, n=9; 
adult vehicle group, n=9). In each graph, baseline dopamine efflux and motor behavior was measured prior to 
injection, represented by the first three time points displayed. Black arrows denote time of injection. Asterisk(s) 
denotes significant difference between amphetamine-treated age groups at a given time point (* p<0.05, ** p<0.01, 
***p<0.001). 
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2.4 DISCUSSION 
In the present study we found that, compared to adults, adolescent rats are less sensitive to the 
motor effects of amphetamine, and that dopamine efflux in the DS of adolescent rats is lower 
than adults. In contrast to the DS, we find very similar effects of amphetamine on dopamine 
efflux in the NAc in adolescence and adulthood. Our finding that there is a region-specific 
reduction in amphetamine-activated dopamine efflux as a function of age suggests that there are 
different mechanisms modulating the availability of dopamine in adolescent rats than in adults. 
Our finding of age-related differences in sensitivity to amphetamine is consistent with 
previous behavior studies showing that, in general, adolescent rats are less sensitive than adults 
to the motor activating effects of psychostimulants such as amphetamine and cocaine (Bolanos et 
al., 1998; Laviola et al., 1999). The unconditioned behavioral responses to psychostimulants 
depend on dopamine function (Beninger, 1983). Decreasing or depleting dopamine, by blocking 
dopamine receptors or through lesions of dopamine cells with 6-OHDA produces 
hypolocomotion, while drugs that enhance dopamine neurotransmission, such as amphetamine 
and cocaine, produce hyperlocomotion and stereotypy (Beninger, 1983). There is a dorsal-ventral 
relationship in the striatum related to this effect in that stereotypy and fine movements are 
attributed to DS dopamine activation, whereas hyperlocomotion is attributed to dopamine 
activation in the NAc (Beninger, 1983; Delfs et al., 1990). Despite the observation that both 
amphetamine-induced hyperlocomotion and stereotypy were reduced in adolescents, we found a 
reduction in dopamine efflux that was selective to the DS. A lack of difference in dopamine 
efflux in the NAc suggests that dopamine-mediated behaviors such as locomotion that are 
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dependent on the functional integrity of this region in adults may be differently regulated in 
adolescents. This finding is similar to that observed by Frantz and colleagues, in that the 
extracellular levels of dopamine in the NAc were similar between adolescent and adult rats under 
basal conditions and after an acute systemic (i.p.) injection of cocaine (Frantz et al., 2007). 
However, this group found that adolescents have lower locomotor activity compared to adults, 
and argued that these age differences in locomotor effects are not mediated by NAc dopamine 
(Frantz et al., 2007). Our findings suggest that a low dose of amphetamine has similar behavioral 
and dopamine efflux effects in both adolescents and adults. These differences in findings may be 
due to differences in the drugs used (cocaine versus amphetamine), the rat strains used (Wistar 
versus Sprague-Dawley), or the time of adolescence studied (early adolescence, postnatal days 
29-31 versus middle adolescence, postnatal days 34-38). 
Our data indicate that at least some of the observed reduced behavioral effects of 
stimulants in adolescents may be attributed to hypoactive dopamine neurotransmission in the DS. 
The NAc and the DS are functionally and structurally distinct. The DS is involved in voluntary 
motor control, instrumental learning and habit formation (Joel and Weiner, 2000), while the NAc 
is involved in reward and reinforced behaviors (Mogenson et al., 1980; Kelley, 2004b). Infusing 
selective dopamine D1 or D2 receptor antagonists into the NAc has been shown to potently 
suppress locomotor responses associated with the motivational state of hunger (Baldo et al., 
2002). Depleting dopamine using 6-OHDA lesions in the NAc has been shown to suppress 
instrumental responding reinforced with food (Heffner and Seiden, 1983). Inactivating the DS 
using lidocaine, on the other hand, has been shown to block the ability of animals to shift 
behavioral control from goal-directed actions to habits (Packard and McGaugh, 1996). 
Furthermore, local infusions of amphetamine into the NAc, but not the DS, have been shown to 
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potentiate conditioned reinforcement (Taylor and Robbins, 1984). At the structural level, the 
NAc and the DS are largely innervated by midbrain dopamine neurons originating from the 
ventral tegmental area and the substantia nigra pars compacta, respectively (Gerfen et al., 1987). 
In addition to the different dopaminergic inputs, there are also different cortical inputs to these 
regions. Cortical glutamatergic afferents innervate the striatum in a topographic gradient, where 
the dorsolateral striatum predominantly receives inputs from sensory and motor cortical areas, 
and the ventromedial striatum (including the NAc) largely receives inputs from the medial 
prefrontal cortex, amygdala and hippocampus (Groenewegen and Berendse, 1994; Voorn et al., 
2004). The different cortical and midbrain influence over the DS compared to the NAc may 
contribute to the difference in dopamine neurotransmission observed in adolescent and adult rats 
in response to amphetamine.  
The age-specific behavioral differences observed in response to pharmacological 
dopamine releasers such as amphetamine may be the result of underlying developmental neural 
changes in the dopamine circuitry during adolescence. Several lines of evidence indicate that the 
mesolimbic and nigrstriatal dopamine systems undergo major remodeling during adolescence. 
Studies have shown that adolescent rodents maintain lower basal extracellular levels of 
dopamine in the striatum than adults (though we do not observe this in our findings), 
accompanied by dopamine receptor overproduction and pruning in striatal regions (Gelbard et 
al., 1989; Andersen et al., 1997; Tarazi et al., 1998a; Badanich et al., 2006; Cao et al., 2007). 
Dopamine receptor binding shifts from being mildly inhibitory to strongly excitatory during 
adolescence into early adulthood (O'Donnell, 2010). Firing rates of midbrain dopamine neurons 
have also been shown to peak during adolescence before decreasing over time into adulthood 
(McCutcheon and Marinelli, 2009). The developmental remodeling of the striatum is of 
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particular interest because of its role in motor behaviors and decision-making processes. 
Previous models had implicated the limbic system, in particular the amygdala and the NAc, in 
functional immaturities of the adolescent brain. However, our present data with the mesolimbic 
and nigrostriatal dopamine systems, as well as a recent electrophysiology study from our 
laboratory, did not find functional differences in the NAc of adolescents as compared to adults. 
Instead, we find reduced dopamine neurotransmission in the DS, a region that is critically 
involved in learning, habit formation and action selections (Jog et al., 1999).  
Dopamine availability relies on reuptake by DAT, but also on synthesis mediated by 
tyrosine hydroxylase (TH), and packaging through the vesicular monoamine transporter-2 
(VMAT2). Based on our current findings, it appears that the dopamine availability in the DS is 
different in adolescents than in adults, and amphetamine may be affecting one or more of the 
mechanisms involved in dopamine availability throughout development. Based on previous 
studies, rat extracellular dopamine concentrations are lower in adolescence than adulthood in the 
NAc and the DS (Andersen and Gazzara, 1993), and DAT expression in rats has been shown to 
be at adult levels by adolescence in the NAc and at adult levels prior to adolescence in the DS 
(Coulter et al., 1996). Furthermore, studies also show that young adolescent rats (P30) have 
decreased accumbal and striatal dopamine synthesis compared to adults (Teicher et al., 1993; 
Andersen et al., 1997). However, together these individual factors do not explain why 
amphetamine causes a lower percentage increase in striatal dopamine from baseline in adolescent 
rats. Amphetamine has been shown to inhibit the reuptake of dopamine and cause release of 
dopamine from presynaptic terminals, through both vesicular and cystolic stores of dopamine 
(Sulzer et al., 1995; Jones et al., 1998). Our finding that there are region-specific differences in 
striatal dopamine transmission in response to amphetamine could indicate that DAT-mediated 
 39 
dopamine availability in the adolescent DS may contribute to its reduced behavioral effects. It is 
also possible that amphetamine may disturb the protein ratios involved in synthesis, packaging, 
and reuptake, thereby causing greater increases in dopamine release in the DS of adults 
compared to adolescents. 
Together, these data suggest that dopamine availability in the DS of adolescent rats may 
be differentially regulated than adults. In Chapters 3 and 4 we attempt to identify possible 
mechanisms that are involved in the reduced dopamine neurotransmission in the adolescent DS.  
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3.0  THE EFFCTS OF STRIATAL TRANSPORTERS IN ADOLESCENT AND 
ADULT RATS 
3.1 INTRODUCTION 
Adolescence is considered a transitional period from childhood to adulthood, which overlaps 
with puberty, a time of sexual maturity (Pickles et al., 1998). It is during adolescence that the 
developing brain undergoes many neural alterations, including a massive loss of axons and 
synapses throughout the neocortex (Huttenlocher, 1984; Arnsten et al., 1994; Andersen et al., 
2000). Brain rates of glucose metabolism plateau in adolescence before declining to adult levels 
(Chugani et al., 1987). Moreover, the adolescent brain undergoes neurogenesis (He and Crews, 
2007), axonal growth (Benes et al., 2000), apoptosis (Markham et al., 2007) and myelination 
(Benes et al., 1994). Collectively, this remodeling is thought to be a form of developmental 
plasticity that allows adolescents to mature into adulthood (Crews et al., 2007). At the same time, 
these changes may make the brain more vulnerable to risky behavior and disease (Spear, 2000). 
The mesocorticolimbic and nigrostriatal dopamine systems, in particular, have been 
shown to undergo major remodeling throughout adolescence (Kelley et al., 2004; Fareri et al., 
2008). Neural alterations in these systems include dopamine receptor overproduction and 
pruning, changes in dopamine turnover and synthesis, and changes in dopamine reuptake 
(Teicher et al., 1993; Baldessarini and Tarazi, 1996; Coulter et al., 1996; Andersen et al., 1997). 
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This remodeling may lead to dynamic changes in the responsivity of the mesocorticolimbic and 
nigrostriatal dopamine systems to external stimuli that may be responsible for some of the 
behavioral changes of adolescents. The developmental dysfunction of these dopamine systems, 
which plays a key role in stress reactivity, cognitive flexibility, goal-directed behaviors, and 
reward processing (Robbins, 1997; Goldman-Rakic, 1998; Kelley, 2004a; Wise, 2005), has been 
implicated in various psychiatric disorders such as schizophrenia (Carlsson and Carlsson, 2006), 
mood (Schildkraut, 1965) and addictive disorders (Koob, 1992). 
We have previously shown that, compared to adults, dopamine efflux in the DS of 
adolescent rats is lower in response to amphetamine. However, there were no changes in 
dopamine efflux in the NAc between age groups. The purpose of this study was to examine the 
underlying mechanisms involved in these region-specific differences as a function of age. 
Amphetamine is known to disrupt the function of DAT, causing efflux of both vesicular 
dopamine and the newly synthesized, “releasable” pool of dopamine, and has also been shown to 
alter VMAT2 activity (Sulzer et al., 1995; Jones et al., 1998; Riddle et al., 2005). Therefore, we 
compared the protein expression of these monoamine transporters in the NAc and DS of 
adolescent and adult rats. Furthermore, we compared the baseline and amphetamine-induced 
dopamine effects of blocking the function of DAT using the uptake blocker nomifensine. 
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3.2 METHODS 
3.2.1 Subjects 
Male Sprague-Dawley rats (Harlan, Frederick, MD) were used for this experiment. Pre-
adolescent juvenile rats (postnatal days 21) and adults (postnatal days 60-70) were received at 
least two weeks prior to experimentation. This two week period allowed animals to habituate to 
the housing, and juvenile rats reached adolescence. By the time of experimentation, adolescent 
rats were between postnatal days 34-38 and the adults were between postnatal days 70-80. All 
subjects were pair housed in a 12 hr light/dark cycle (lights on at 19:00).  All experiments and 
dissections were conducted during the animals’ dark (active) phase. Animals had ad libitum 
access to water and rat chow food. Experiments were performed in accordance with and approval 
by the ethical guidelines of the Institutional Animal Care and Use Committee at the University of 
Pittsburgh. 
3.2.2 Western blot 
Tissue dissection. All tissue dissections were conducted between 13:00 and 15:00. Adolescent 
(n=4) and adult (n=4) rats were anesthetized with chloral hydrate (400 mg/kg), decapitated, and 
their brains removed rapidly and immediately placed in an iced metal brain slicer matrix (Ted 
Pella, Inc). Using the metal matrix as a guide, 1 mm slices were made using razor blades. From 
these 1 mm slices, the NAc and DS tissue were free-hand dissected using a scalpel (see Figure 3-
1). Dissected tissue for each region of each animal were stored separately in Eppendorf tubes and 
immediately frozen and stored at -80°C, until used. The dissected tissue was homogenized with a 
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Polytron homogenizer in buffer D (20 mM HEPES, 125 mM NaCl, 10% glycerol, 1 mM EDTA, 
1 mM EGTA, 1 mM DTT, pH 7.6), containing protease inhibitors (Pierce). Triton X-100 was 
added to a final concentration of 1%, and the samples were incubated with rotation for 1 hr at 
4°C. Samples were centrifuged twice at 4°C at 10,000 × g for 10 min. The supernatant was 
collected and measured for protein concentration using a spectrophotometer using a BCA reagent 
(Pierce).  
Western blot analysis. Western blot analysis was performed as described previously 
(Egana et al., 2009; Cartier et al., 2010). Samples containing 20% sample buffer were separated 
by SDS-PAGE on 10% Tris-glycine polyacrylamide gels by loading 100 μg of protein per lane 
and transferred to nitrocellulose membranes using the Bio-Rad system. Nitrocellulose 
membranes were first blocked for 1 hr in TBS buffer (50 mM Tris-HCl, 150 mM NaCl, 0.2% 
Tween 20, pH 7.5) containing 5% dry milk and then incubated with the indicated primary 
antibody for 1 hr in blocking buffer, washed three times for 10 min each, and incubated with a 
horseradish peroxidase-conjugated secondary antibody. Following all antibody incubations, 
membranes were washed three times with TBS buffer, and protein bands were visualized using 
the West Pico SuperSignal system (Pierce) and LabWorks software. Densitometric analyses of 
protein bands were accomplished using ImageJ NIH software. The protein contents of DAT and 
VMAT2 were expressed as a ratio of tubulin band densities to ensure that changes in protein 
levels were not due to sample loading variances. Primary antibodies against DAT MAB369 and 
VMAT2 AB1598P were from Millipore and primary antibody against the control protein α-
tubulin was from Sigma-Aldrich. Secondary antibodies conjugated with horseradish peroxidase 
were Anti-Rat IgG (Jackson) for DAT, Protein A (GE Healthcare UK Limited) for VMAT2, and 
Goat Anti-Mouse IgG (H + L) for tubulin (Bio-Rad Labs). Primary antibody concentrations 
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included anti-DAT MAB369 (1:1,000), anti-VMAT2 AB1598P (1:500), and anti-tubulin T6074 
(1:1,000). Secondary antibody concentrations were 1:5,000 for DAT, 1:4,000 for VMAT2, and 
1:10,000 for tubulin. 
Tissue samples from the same adolescent and adult animals were used for measuring 
DAT and VMAT2 protein levels. Due to the low levels of DAT protein in adolescent animals 
(NAc and DS), data were replicated multiple times using different primary antibodies in order to 
provide a quantitatively measurable signal from adolescent tissue. The data reported here used 
the primary antibody listed above. However, due to a loss of sample from multiple replications, 
an n = 3 for adults is reported.  
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Figure 3-1 Regions for tissue dissection 
Western blot analysis of DAT and VMAT2 used tissue that was free-hand dissected bilaterally from both the NAc 
(outlined in green) and the DS (outlined in red) of adolescent and adult rats. General regions of dissection in this 
diagram are indicated on a standard adult rat atlas image (Paxinos and Watson, 1998).  
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3.2.3 Surgical Procedure 
Surgeries were performed between the hours 08:00 and 10:00. To implant microdialysis probes, 
rats were anesthetized with isoflurane, placed on a heating pad, and their heads secured in a 
stereotaxic apparatus with blunt ear bars. A small incision was made in the skin over the skull 
and the area irrigated with lidocaine. Dialysis probes were bilaterally implanted, with one probe 
in the DS (for adolescents: AP +0.7 from bregma, ML +2.0 from bregma, and DV –5.0 from 
skull; and for adults: AP +1.6, ML +2.2, DV –6.0 from skull) and one probe in the NAc (for 
adolescents: AP +1.0 from bregma, ML +1.2 from bregma, and DV –7.0 from skull; and for 
adults: AP +1.2, ML +1.1, DV –8.4 from skull). Coordinates for the dialysis probes were 
according to the atlas of Paxinos and Watson (Paxinos and Watson, 1998). Dialysis probes were 
constructed of Hospal AN69 polyacrylonitrile dialysis tubing (Renal Care, Lakewood, CO), with 
an outer diameter of 330 µm and an exposed tip of 1.0 mm for adolescent rats and 2.0 mm for 
adult rats. To account for the smaller size of the adolescent brain, dialysis probes with a smaller 
exposed tip were used. Dialysis probes were secured in a head cap consisting of dental acrylic 
and were fastened to the skull using two skull screws. Immediately following surgery, dialysis 
probes were connected to a liquid swivel balance arm assembly, and animals were singly housed 
in a clear polycarbonate cage with fresh bedding. Animals were housed in a temperature and 
humidity controlled room on the same light/dark schedule used in the vivarium (lights on at 
19:00). The dialysis probes were perfused at a rate of 1.5 µL/min with a Ringer’s solution (in 
mM: 145 NaCl, 2.7 KCl, 1.0 MgCl2, and 1.2 CaCl2). Animals received rat chow softened with 
an acetaminophen solution. Rats were allowed approximately 24 hr to recover from the surgery 
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prior to the collection of microdialysis samples, which is accepted as a sufficient period of time 
for brain tissue to normalize after probe implantation (Krebs-Kraft et al., 2007). Our laboratory 
has previously shown previously that a 24 hr recovery period is also sufficient for the overall 
health of the animals to return to normal (Moghaddam and Gruen, 1991; Moghaddam and 
Bunney, 1993; Jedema and Moghaddam, 1994; Moghaddam and Bolinao, 1994). Thus, animals 
in this study did not show obvious signs of post-surgery distress; rather, the animals groomed 
normally, ate food and drank water, and had no signs of bleeding or infection around the wound 
or head cap. Rats had ad libitum access to food and water during the recovery period, but not 
during the experiment. 
3.2.4 Microdialysis 
On the day of the experiment, rats remained in their home-cage for collection of samples and 
behavioral testing. Dialysis experiments began between 09:00 and 11:00. Probes were perfused 
with Ringer's solution only (as above) at a flow rate of 2.0 μL/min during sample collection. 
Dialysate samples were collected every 20 min for the duration of each experiment and 
immediately injected into a high-performance liquid chromatography system with 
electrochemical detection for the analysis of dopamine, as described previously (Adams and 
Moghaddam, 1998). One hour of baseline samples were analyzed before the systemic or local 
administration of drug. For local drug administration, nomifensine (dissolved in Ringer’s 
solution) was infused directly through the microdialysis probes, at a flow rate of 2.0 μL/min. For 
analysis, dialysate samples were injected immediately onto an HPLC system with 
electrochemical detection for analysis of dopamine, with a detection limit of approximately 5 
fmol.  
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3.2.5 Drugs 
Amphetamine (1.0 mg/kg; Sigma-Aldrich) and nomifensine (20µM; Sigma-Aldrich) were 
dissolved in 0.9% saline and frozen for a maximum of 1 week prior to use. Nomifensine 
dissolved in saline at a concentration of 20 µM was further diluted to a concentration of 5µM in 
the Ringer’s solution prior to each infusion experiment and was used immediately. Once a stable, 
resting dopamine baseline was reached, dialysis probes were infused with nomifensine (5µM). 
Once a stable dopamine baseline was reached during nomifensine infusion, amphetamine (1.0 
mg/kg) was administered systemically (i.p.).  
The dose of nomifensine used in this study was chosen based on previous studies that 
show low doses of nomifensine infusion caused sustained increases in striatal dopamine (Adams 
et al., 2002; Ukai et al., 2004). The dose of amphetamine used in this study was consistent with 
our previous study (Chapter 2), showing that in adolescence and adulthood this dose caused 
increases in striatal dopamine and associated behaviors.  
3.2.6 Histology 
After completion of microdialysis experiments, rats were anesthetized with chloral hydrate (400 
mg/kg) and perfused intracardially with 0.9% NaCl. Brains were removed and stored in a 10% 
Formalin solution. Serial coronal sections of 250 µm thickness were taken through the regions of 
interest and then mounted on glass slides and stained with cresyl violet. Stained sections were 
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then evaluated for accuracy of probe placement. Only data from placements within the brain 
region of interest were used for further analysis (Figure 3-2). 
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Figure 3-2 Microdialysis probe placements 
Microdialysis probe placement for rats included in the study. Probes were placed bilaterally in the NAc and DS of 
adolescent and adult rats. Black bars represent the approximate location of probe placements, overlaid on standard 
adult rat atlas images (Paxinos and Watson, 1998). The size of black bars represents the approximate size of the 
exposed dialysis tip: 1.0 mm for adolescents, 2.0 mm for adults. Numbers represent distance (in millimeters) 
anterior to bregma for adult animals.  
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3.2.7 Data analysis 
For Western blot analysis, results are presented as optical density ratios (mean ± sem). Statistical 
analysis for western blot data was conducted using student t-tests. Significance was set at p < 
0.05. 
Microdialysis data were analyzed as described previously (Adams and Moghaddam, 
1998; Pehrson and Moghaddam, 2010). The microdialysis data were expressed as a percentage 
of baseline dopamine efflux (mean ± sem), where baseline was defined as mean of the three 
baseline values obtained immediately before a pharmacological manipulation. Baseline means 
for each group, reported as fmol/μl, were analyzed using student t-tests. Statistical analysis of 
these dependent measures were conducted using two-factor repeated measures ANOVAs with 
age or drug treatment as the between-subjects factors and time as the within-subjects factor. 
Significance was set at p < 0.05. For microdialysis, five-eight subjects per group were required 
based on an estimated effect size (considering previous work in our laboratory).  
3.3 RESULTS 
3.3.1 Protein expression 
Given the region specific differences in amphetamine-induced dopamine efflux between 
adolescent and adult rats (Section 2.4), we sought to investigate the molecular mechanisms 
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responsible for these differences. We used Western blot analysis to measure levels of proteins 
involved in dopamine availability and the effects of amphetamine, including DAT and the 
monoamine vesicular transporter-2 (VMAT-2) of adolescent and adult rats. Protein analyses 
showed that adolescents displayed reduced DAT protein level expression in both the NAc (t5 = 
3.7, p < 0.05) (Figure 3-3A) and the DS (t6 = 4.05, p < 0.01) (Figure 3-3B) compared to adults. 
There were no significant differences between either age group in VMAT-2 levels in the NAc (t6 
= 1.14, n.s.) (Figure 3-3A) or the DS (t6 = -0.26, n.s.) (Figure 3-3B). 
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Figure 3-3 Protein expression of DAT and VMAT2 in adolescents and adults 
Adolescent rats have decreased levels of DAT in both the NAc and the DS. Protein expression levels of DAT 
(adolescents, n=4; adults, n=3) and VMAT2 (n=4 for each group) were measured using Western blot analysis in the 
A) NAc and B) DS of adolescent (orange bars) and adult (blue bars) rats. The band images shown are from the same 
gel of the representative of adolescent and adult rats used to measure each protein. All protein optical densities were 
normalized to tubulin, shown along the bottom of the figure. Asterisk(s) denotes significant differences between age 
groups (* p<0.05, **p<0.01). 
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3.3.2 Dopamine Efflux 
Although reduced DAT levels were observed in adolescents compared to adults in both the NAc 
and DS, the functional differences may be different in these regions, suggesting that reduced 
DAT function in the DS may account for reduced effects of amphetamine on dopamine efflux in 
adolescent DS (Figure 3-3). To test the validity of this mechanism, we compared the effect of 
locally applied DAT inhibitor nomifensine on basal and amphetamine-activated extracellular 
dopamine levels. The baseline means (in fmol/μl) for the NAc are 0.26 ± 0.09 in adolescents (n = 
11) and 0.48 ± 0.22 in adults (n = 11), with no significant difference between age groups (t20 = -
0.955, n.s.). The baseline mean (in fmol/μl) for the DS is 0.92 ± 0.37 in adolescents (n = 13) and 
0.37 ± 0.14 in adults (n = 11), with no significant difference between age groups (t22 = 1.32, n.s.). 
Application of the DAT inhibitor nomifensine produced a near 6-fold increase in dopamine 
efflux that was sustained throughout drug infusion in the NAc (Figure 3-4A) and DS (Figure 3-
4B) of both adolescents and adults (time main effect, F(11, 220) = 34.82, p<0.0001). There were 
no significant age differences in dopamine efflux in the NAc (time × age interaction, F(11, 220) 
= 1.03, n.s.). There was, however, a trend toward significance in the DS (time × age interaction, 
F(11, 253)=1.82, p = 0.052), such that adolescents demonstrated lower dopamine efflux over 
time compared to adults.  
After nomifensine infusion caused a plateau in increased dopamine levels, systemic 
administration of amphetamine (1.0 mg/kg) caused significant decreases in dopamine efflux in 
the adolescent NAc (treatment × age interaction, F(10, 80) = 2.38, p < 0.05) and DS (treatment × 
age interaction, F(10, 80) = 2.38, p < 0.05), compared to saline controls. Amphetamine had no 
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effect on dopamine efflux in the adult NAc (treatment × age interaction, F(10, 90) = 0.54, n.s.) or 
the DS (treatment × age interaction, F(10, 80) = 0.87, n.s.), compared to saline controls (Figure 
3-4C). However, amphetamine did not cause any significant age dependent differences in 
dopamine efflux during nomifensine infusion in the NAc (time × age interaction, F(10, 99) = 
0.47, n.s.) (Figure 3-4C) or in the DS (time × age interaction, F(10, 60) = 0.53, n.s.) (Figure 3-
4D). There were also no age differences in dopamine efflux in response to the saline vehicle 
administration during nomifensine infusion in the DS (time × age interaction, F(10, 100) = 0.64, 
n.s.) (Figure 3-4D), though there was a significant age difference in the NAc (time × age 
interaction, F(10, 80) = 2.43, p < 0.05).  
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Figure 3-4 Dopamine efflux in response to nomifensine and amphetamine 
Blockade of DAT produced similar regional effects on dopamine efflux in both adolescents and adults. The DAT 
inhibitor nomifensine was infused directly into the NAc and DS of adolescent (orange) and adult (blue) rats. 
Dopamine efflux was measured in the A) NAc (adolescent group, n=11; adult group, n=11) and B) DS (adolescent 
group, n=14; adult group, n=11). When maximum dopamine efflux was reached for at least 3 consistent time points 
during nomifensine infusion, animals were given an i.p. injection of 1.0mg/kg amphetamine (squares) or 0.9% saline 
vehicle (circles). Dopamine efflux continued to be measured in the C) NAc (adolescent amphetamine group, n=6; 
adult amphetamine group, n=6; adolescent vehicle group, n=5; adult vehicle group, n=5) and D) DS (adolescent 
amphetamine group, n=6; adult amphetamine group, n=5; adolescent vehicle group, n=8; adult vehicle group, n=6) 
following injection. In graphs A) and B), baseline dopamine efflux was measured prior to infusion, represented by 
the first three time points displayed. In graphs C) and D), baseline dopamine efflux was measured after nomifensine 
infusion caused a plateau in dopamine, represented by the first three time points displayed. Black bar denotes 
nomifensine infusion. Black arrow denotes time of injection.  
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3.4 DISCUSSION 
In the present study we found that dopamine’s hypoactive response to amphetamine in 
adolescent rats observed in Chapter 2 is likely not due to mechanisms of dopamine packaging or 
reuptake. Though our findings showed that the density of DAT is lower in the adolescent NAc 
and DS compared to adults, blocking DAT locally in these regions produced similar effects on 
dopamine efflux in these regions regardless of age, suggesting that the differences in the density 
of DAT alone is not responsible for the region-specific effects of amphetamine on dopamine 
efflux seen previously. Furthermore, our findings indicate that there is no difference in the 
density of the dopamine packaging protein, VMAT2. Thus, other mechanisms besides dopamine 
packaging and reuptake, such as the rate of dopamine synthesis, may be responsible for the 
reduced dopamine neurotransmission observed in the adolescent DS. 
Dopamine in the striatum relies heavily upon the function of DAT and VMAT2. DAT is 
responsible for transporting dopamine that is released into the synapse back into the presynaptic 
terminal of the dopamine neuron. VMAT2 is then responsible for transporting cytosolic, newly 
synthesized dopamine into synaptic vesicles, making dopamine available for synaptic release. 
Psychostimulants such as amphetamine are known to be modulators of dopamine 
neurotransmission, as amphetamine has been shown to reverse the reuptake of dopamine through 
DAT and cause increases in extracellular dopamine (Sulzer et al., 1995; Jones et al., 1998). 
Therefore, our previous finding that amphetamine caused reduced increases in dopamine efflux 
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in the DS of adolescent rats compared to adolescents indicated that DAT-mediated dopamine 
availability in the adolescent DS contributed to the observed reduced effects.  
However, the data in this study suggest that though adolescents express less DAT in both 
the NAc and DS than adults, the functional consequences of DAT inhibition are similar in both 
regions. First, we will focus on the developmental pattern of expression of DAT in the striatum. 
Our data demonstrated that DAT is lower in both the NAc and DS of adolescent than adult rats. 
This finding is consistent with previous studies that observed higher DAT levels in adulthood 
compared to adolescence (Tarazi et al., 1998b; Volz et al., 2009). Conversely, there are other 
conflicting reports that have observed either DAT levels peak in adolescence and gradually 
decline with age (Meng et al., 1999; Moll et al., 2000), or that DAT expression reaches adult 
levels prior to or during adolescence in the NAc and DS (Coulter et al., 1996). The differences in 
striatal DAT levels may be due to the different experimental paradigms, techniques and ages 
used (e.g. early versus middle versus late adolescent ages) may contribute to these varying and 
conﬂicting results. 
Age differences in the striatal expression of DAT might suggest functional differences in 
dopamine reuptake as a consequence. Yet, our findings show that there are no age-related 
differences in dopamine efflux when blocking dopamine reuptake through local infusion of a 
DAT inhibitor, nomifensine, in the NAc and DS. Our results do show, however, a trend towards 
significance in the DS, with adolescent rats having smaller increases in dopamine efflux than 
adults. Since nomifensine blocks dopamine reuptake and the dopamine released is impulse 
dependent, our findings might suggest that adolescent animals have reduced levels of dopamine 
in the DS compared to adults. Though our measures of basal dopamine level concentrations in 
the DS do not show a significant age difference. Previous reports, however, indicate that basal 
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dopamine levels are lower in both the DS and NAc of adolescent rats, using either in vivo 
microdialysis to measure dopamine levels or dissected  striatal tissue measured on HPLC 
(Badanich et al., 2006; Cao et al., 2007). Further studies should be conducted to assess basal 
levels of dopamine in these striatal subregions across adolescence (early, middle, late) and 
compared to adulthood.  
Our results also indicated that the blockade of DAT similarly prevented any further 
effects of amphetamine administration on dopamine efflux in the NAc and the DS. This suggests 
that DAT blockade is functionally similar in both striatal subregions of adolescents and adults, 
regardless of age-related differences in DAT expression. Consistent with these data, Volz and 
colleagues have previously shown that while adolescent rats have lower DAT expression in 
striatal tissue, there are increased levels of functionally active DAT within this region as 
measured by dopamine transport velocities and DAT immunoreactivity (Volz et al., 2009). 
Although this study did not distinguish between dorsal and ventral striatum, the results suggest 
that although adolescent rats express less DAT, these DATs are functionally more efficacious at 
dopamine clearance than those expressed in adults. Our findings of a similar pattern of dopamine 
increase in both striatal subregions during adolescence and adulthood in response to DAT 
blockade support this equivalent reuptake hypothesis. 
Our previous finding that there are region-specific differences in striatal dopamine efflux 
in response to amphetamine suggested that DAT-mediated dopamine availability in the 
adolescent DS may contribute to its reduced behavioral effects. However, together with the 
findings of this study, the differences in the density of DAT does not explain why amphetamine 
causes a greater percentage increase from baseline in DS dopamine of adult rats, but similar 
 60 
increases in NAc dopamine. Other mechanisms involved in dopamine availability, such as the 
synthesis rate limiting enzyme, tyrosine hydroxylase, may be involved.  
Though DAT may not explain the hypoactive dopamine response in the DS of 
adolescence to amphetamine, DAT plays an important role in dopaminergic transmission that 
can lead to dysfunction in disorders such as ADHD. The dysfunction of the mesocorticolimbic 
and nigrostriatal dopamine systems has been implicated in the pathophysiology of ADHD 
through studies that suggest there is an overexpression of the DAT gene as well as imaging 
studies that show the efficiency of treatment with dopamine reuptake inhibitors such as 
methylphenidate (Faraone et al., 2005).There have been other groups that have found that striatal 
DAT density is significantly higher in patients with ADHD compared to normal controls (Cheon 
et al., 2003; Krause, 2008). Furthermore, amphetamine-like stimulants that target DAT are 
commonly prescribed to human youths with ADHD for primary therapeutic treatment (Kutcher 
et al., 2004; Zhu and Reith, 2008), though little is known about the impact of these drugs on 
dopamine neurotransmission at this age or the longer term consequences. Therefore, a greater 
understanding of the normal development of DAT in the adolescent striatum is important for 
determining the underlying mechanisms involved in the disruption of DAT function in 
psychiatric illness and provide insight into prevention. 
In summary, similar patterns of dopamine reuptake in both the NAc and DS suggested 
that there are other mechanisms that govern dopamine availability in adolescents that selectively 
target the DS, making it hyporesponsive to stimulants such as amphetamine. Our data strongly 
indicate that this regionally selective mechanism does not involve changes in dopamine reuptake 
or packaging, but instead may involve differences in dopamine synthesis in the DS of 
adolescents. We address this possibility in Chapter 4. 
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4.0  THE EFFECTS OF DOPAMINE SYNTHESIS IN ADOLESCENT AND ADULT 
RATS 
4.1 INTRODUCTION 
Dopamine is a neuromodulator involved in regulating various behaviors such as learning (Wise, 
2004), cognitive flexibility (Stefani and Moghaddam, 2006; Robbins and Roberts, 2007), reward 
perception (Schultz et al., 1997; Berridge and Robinson, 1998), and motor movements 
(Beninger, 1983; LeMoal and Simon, 1991). There are anatomically and functionally distinct 
subgroups of dopamine neurons in the ventral midbrain that innervate forebrain structures such 
as the nucleus accumbens (NAc), and dorsal striatum (DS) (Carlsson et al., 1962). The DS, 
which plays an important role in voluntary motor control (Joel and Weiner, 2000), as well as 
instrumental learning (Balleine et al., 2009), is largely innervated by dopamine neurons from the 
substantia nigra pars compacta (Gerfen et al., 1987). The NAc, on the other hand, which is 
thought to play a key role in adolescent risk taking and sensation seeking (Ernst et al., 2006; 
Casey et al., 2008; Steinberg, 2008), is innervated by dopamine neurons from the ventral 
tegmental area (Gerfen et al., 1987).  
It is during adolescence that the mesolimbic and nigrostriatal dopamine systems undergo 
major remodeling (Kelley et al., 2004; Fareri et al., 2008). Neural alterations in these systems 
include dopamine receptor overproduction and pruning, changes in dopamine turnover and 
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synthesis, and changes in dopamine reuptake (Teicher et al., 1993; Baldessarini and Tarazi, 
1996; Coulter et al., 1996; Andersen et al., 1997). This remodeling may lead to dynamic changes 
in the responsivity of the dopamine system to external stimuli that may be responsible for some 
of the behavioral changes of adolescents. For example, changes in reward sensitivity in 
adolescence (Spear, 2000; Kelley et al., 2004) may be due to dopamine mediated neuronal 
remodeling in striatal, limbic and frontal cortical regions in preparation for adulthood (LeMoal 
and Simon, 1991). The developmental dysfunction of the mesocorticolimbic and nigrostriatal 
dopamine systems has been implicated in various psychiatric disorders such as schizophrenia 
(Carlsson and Carlsson, 2006), mood (Schildkraut, 1965) and addictive disorders (Koob, 1992).  
Our previous studies have shown that dopamine neurotransmission in the DS of 
adolescent rats is hypoactive in response to acute amphetamine compared to adults. Since 
amphetamine is known to effect dopamine release via the dopamine transporter (DAT), we have 
also shown that this hypoactive response is likely not due to age-related differences of the 
protein density of DAT alone. The purpose of this study was to examine other underlying 
mechanisms involved in the hypoactive function of dopamine in the adolescent DS. We 
measured the expression of the rate-limiting enzyme in dopamine synthesis, tyrosine hydroxylase 
(TH) in the NAc and DS of adolescent and adult rats. Further, we examined the behavioral 
effects of blocking dopamine synthesis by systemically administering a TH inhibitor.  
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4.2 METHODS 
4.2.1 Subjects 
Adolescent (PND 34-38, ~130-150 g) and adult (PND 70-80, ~330-400 g) male Sprague-Dawley 
rats (Harlan) were used. Pre-adolescent juvenile rats (postnatal day 21) and adults were received 
at least two weeks prior to experimentation, allowing animals to habituate to the housing. During 
this time, juvenile rats reached adolescence (PND 34-38). All subjects were pair housed in a 12 
hr light/dark cycle (lights on at 19:00).  Experiments were conducted during the animals’ dark 
(active) phase. All animals had ad libitum access to water and rat chow food. All animal 
experiments were performed in accordance with and approval by the ethical guidelines of the 
Institutional Animal Care and Use Committee at the University of Pittsburgh. 
4.2.2 Western Blot 
Tissue samples from the same adolescent and adult animals used to measure DAT and VMAT2 
in Chapter 3 were used for measuring TH protein levels. There was an n of 4 for each group.  
Tissue dissections and Western blot analysis were conducted as described previously in 
Chapter 3 (Section 3.2.2). TH protein levels were expressed as a ratio of tubulin band densities 
to ensure that changes in protein levels were not due to sample loading variances. Primary 
antibody against TH AB152 was from Millipore and primary antibody against the control protein 
α-tubulin was from Sigma-Aldrich. Secondary antibodies conjugated with horseradish 
peroxidase were Protein A for TH (GE Healthcare UK Limited) and Goat Anti-Mouse IgG (H + 
L) for tubulin (Bio-Rad Labs). Primary antibody concentration for anti-TH AB152 and anti-
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tubulin T6074 was 1:1,000. Secondary antibody concentrations were 1:4,000 for TH and 
1:10,000 for tubulin. 
4.2.3 Behavior 
Behavioral experiments began between 09:00 and 11:00. Adolescent and adult rats were 
individually placed in a clear polycarbonate cage with fresh bedding, with no access to food or 
water, in a temperature and humidity controlled room on the same light/dark schedule used in the 
vivarium (lights on at 19:00). Animals were given 1 hr to habituate to the experimental cage 
before receiving pharmacological manipulation. Motor behavior was quantified as described in 
Chapter 2 (Section 2.2.4).  
4.2.4 Drugs 
Alpha-methyl-DL-tyrosine (50 mg/kg; TCI America) and amphetamine (1.0 mg/kg; Sigma-
Aldrich) were dissolved in 0.9% saline. Alpha-methyl-DL-tyrosine was used immediately, while 
amphetamine was frozen for a maximum of 1 week prior to use. Both alpha-methyl-DL-tyrosine 
and amphetamine were both administered systemically (i.p.).  
The dose of alpha-methyl-DL-tyrosine used in this study was chosen based on previous 
studies demonstrating that pre-treatment with 50 mg/kg (i.p.) alpha-methyl-DL-tyrosine 
attenuates the stimulation of locomotor activity induced by amphetamine (Finn et al., 1990; Di 
Lullo and Martin-Iverson, 1991). The dose of amphetamine used in this study was consistent 
with our use in previous studies (Chapters 2 and 3), showing that this dose (1.0 mg/kg) leads to 
increased dopamine efflux and associated motor behaviors in adolescent and adult rats.  
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4.2.5 Behavior experimental design 
Animals were given one hour to habituate to their novel cage environment. Behavior was 
immediately recorded once the animal was placed in its cage. After one hour of habituation, 
animals were pre-treated with alpha-methyl-DL-tyrosine (50 mg/kg), administered systemically 
(i.p.). After 2 hr of pre-treatment, animals were given another systemic (i.p.) injection of either 
0.9% saline (1 ml/kg) or amphetamine (1.0 mg/kg). The animals’ behavior was recorded for 
another 2 hr.  
4.2.6 Data analysis 
For Western blot analysis, results are presented as optical density ratios (mean ± sem). Statistical 
analysis for western blot data was conducted using student t-tests. Significance was set at p < 
0.05. 
Behavior data were separately expressed as the number of infrared beam breaks (for 
either XY ambulations or fine movements) within a 5 min bin (mean ± sem). Statistical analysis 
of these dependent measures was conducted using two-factor repeated measures ANOVAs, with 
age or drug treatment as the between-subjects factors and time as the within-subjects factor. 
Significance was set at p < 0.05. Five-eight subjects per group were required based on an 
estimated effect size (considering previous work in our laboratory).  
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4.3 RESULTS 
4.3.1 Protein expression 
We used Western blot analysis to measure levels of protein in the NAc and DS of adolescent and 
adult rats. Protein analyses showed that TH protein expression levels, relative to the 
housekeeping protein tubulin, were selectively lower in DS of adolescents compared to adults (t6 
= 3.45, p < 0.05) (Figure 4-1B) while levels were comparable in NAc of both age groups (t6 = 
0.45, n.s.) (Figure 4-1A).  
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Figure 4-1 Protein expression of TH in adolescents and adults 
Adolescent rats have decreased levels of TH in the DS. Protein expression levels TH (n=4 for each group) were 
measured using Western blot analysis in the (A) NAc and (B) DS of adolescent (orange bars) and adult (blue bars) 
rats. The band images shown are from the same gel of the representative of adolescent and adult rats used to 
measure the protein. All protein optical densities were normalized to tubulin, shown along the bottom of the figure. 
Asterisk(s) denotes significant differences between age groups (* p<0.05). 
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4.3.2 Behavior 
To examine the role of TH regulation on dopamine-mediated motor behaviors, animals were 
pretreated with the TH inhibitor alpha-methyl-DL-tyrosine (50 mg/kg, i.p.) for 2 hrs prior to 
amphetamine (1.0 mg/kg, i.p.) administration. Amphetamine exposure after alpha-methyl-DL-
tyrosine pretreatment significantly increased locomotor activity in adolescents (treatment × age 
interaction, F(29, 464)=4.26, p<0.0001) and adults (treatment × age interaction, F(29, 406) = 
3.52, p < 0.0001), as well as stereotypy in adolescents (treatment × age interaction, F(29, 406) = 
3.52, p < 0.0001) and adults (treatment × age interaction, F(29, 464) = 2.89, p < 0.0001), 
compared to saline controls. Adolescents and adults responded similarly to amphetamine induced 
locomotor ambulations (time × age interaction, F(29, 406) = 0.93, n.s.) (Figure 4-2A), whereas 
amphetamine significantly reduced stereotyped movements in adolescents (time × age 
interaction, F(29, 406) = 1.74, p < 0.01) (Figure 4-2B) compared to adults. Vehicle 
administration showed no effect on locomotion (time × age interaction, F(29, 406) = 1.21, n.s.) 
(Figure 4-2A) or fine movements between groups (time × age interaction, F(29, 406) = 1.26, 
n.s.) (Figure 4-2B). 
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Figure 4-2 Behavior in response to alpha-methyl-DL-tyrosine and amphetamine 
TH inhibition caused lower increases in fine movements in response to amphetamine exposure in adolescent rats. 
Adolescent (orange) and adult (blue) rats were pretreated with alpha-methyl-DL-tyrosine before given an i.p. 
injection of 1.0mg/kg amphetamine (squares) or 0.9% saline vehicle (circles). Motor behavior was measured for 
each animal, expressed as (A) ambulations (n=10 for each group) and (B) fine movements (n=10 for each group). In 
each graph, baseline motor behavior during pretreatment was measured prior to amphetamine injection, represented 
by the first six time points displayed. Black arrow denotes time of amphetamine injection.  
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4.4 DISCUSSION 
In the present study we found that TH expression is reduced in the DS of adolescent rats 
compared to adults. Similar levels of TH expression were seen in both age groups in the NAc. 
Our data further indicate that blocking dopamine synthesis with a TH inhibitor attenuates 
amphetamine-induced stereotypy (mediated by dopamine in the DS) in adolescents to a greater 
degree than adults. These findings support the idea that reduced protein expression of TH in the 
DS of adolescents leads to diminished dopamine synthesis in this region, and therefore reduced 
dopamine availability, which likely contributes to the mechanism for reduced amphetamine-
induced dopamine activity in the DS during adolescence.  
Little is known about the developmental trajectory of TH or dopamine synthesis 
throughout development. Dopamine synthesis is mediated by TH, a rate limiting enzyme that 
converts tyrosine to L-DOPA (Molinoff and Axelrod, 1971). Dopamine synthesis and 
availability are activity dependent. TH is regulated long-term through gene expression and short-
term through feedback inhibition by catecholamines, allosteric regulation, and phosphorylation 
(Kumer and Vrana, 1996). We observed that there are region-specific differences in TH 
expression between adolescents and adults. Lower levels of TH in the adolescent DS would lead 
to reduced dopamine synthesis, potentially leading to reduced dopamine transmission in this 
region. Our finding that amphetamine-induced stereotypy, a motor behavior dependent on 
dopamine neurotransmission in the DS (Beninger, 1983), was selectively attenuated in 
adolescents by a TH inhibitor further suggests adolescent DS may also have a lower functional 
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state of TH activity. However, we did not measure extracellular dopamine levels in response to 
alpha-methyl-DL-tyrosine, and it is unclear if the dose administered, and the time allotted for 
pretreatment prior to amphetamine administration was sufficient to significantly deplete 
dopamine stores in the NAc or the DS. Therefore, we cannot directly correlate changes in 
behavior in response to TH inhibition with changes in extracellular dopamine levels. Further 
studies are needed to establish which of these mechanisms governing TH activity contribute to 
reduced TH protein expression and the functional consequences of reduced TH in the adolescent 
DS.   
Our data strongly indicate that the regionally selective mechanism for reduced 
amphetamine-induced dopamine activity in the adolescent DS involves expression of TH.  This 
study provides further data to support the claim that dopamine neurotransmission is selectively 
hypofunctional in the DS but not the NAc of adolescents. The NAc and the DS receive 
dopaminergic midbrain projections from the ventral tegmental area and the substantia nigra pars 
compacta, respectively (Joel and Weiner, 2000). The distinct anatomical and structural 
connectivity of these striatal regions may explain the different functional roles these regions play 
in various behaviors. The DS is involved in voluntary motor control, instrumental learning and 
habit formation (Joel and Weiner, 2000), while the NAc is involved in reward and reinforced 
behaviors (Mogenson et al., 1980; Kelley, 2004b). Blocking dopamine receptors in the NAc has 
been shown to potently suppress locomotor responses associated with the motivational state of 
hunger (Baldo et al., 2002). Depleting dopamine in the NAc has been shown to suppress 
instrumental responding reinforced with food (Heffner and Seiden, 1983), while inactivating the 
DS, on the other hand, has been shown to block the ability of animals to shift behavioral control 
from goal-directed actions to habits (Packard and McGaugh, 1996). Furthermore, administering 
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amphetamine locally into the NAc, but not the DS, has been shown to potentiate conditioned 
reinforcement (Taylor and Robbins, 1984).  
Understanding the remodeling of the striatum throughout adolescent development is 
important because of the striatum’s role in motor behaviors and decision-making processes. 
Previous models have implicated the limbic system, in particular the amygdala and the NAc, in 
functional immaturities of the adolescent brain. However, our present data with the dopamine 
system, as well as recent electrophysiology study from our laboratory (Sturman and 
Moghaddam, 2012), do not find functional differences in the NAc of adolescent rats as compared 
to adults. Instead, we find reduced dopamine neurotransmission in the DS, a region that is 
critically involved in learning, habit formation and action selection (Jog et al., 1999). 
Dopamine’s action in the striatum is primarily inhibitory (Bamford et al., 2004). Furthermore, 
dopamine is considered to be involved in strengthening synaptic corticostriatal connections by 
modulating striatal interneurons (Wickens et al., 2007a; Surmeier et al., 2011), and reduced 
dopamine activity might suggest that the normal inhibitory control of dopamine is reduced in the 
DS of adolescents. This notion is consistent with hyper-responsiveness of adolescent DS neurons 
to salient events such as reward expectancy (Sturman and Moghaddam, 2012). Reduced 
dopamine neurotransmission in the DS during this developmental phase may influence DS-
dependent behavioral functions, such as response selection and habit formation, and may serve 
as a mechanism for increased vulnerability to dopamine related illnesses like schizophrenia and 
addiction. Thus, reduced dopamine activity in this region during adolescence may enhance the 
function of afferent input that mediates learning and habit formation. 
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5.0  GENERAL DISCUSSION 
5.1 SUMMARY AND INTERPRETATION OF FINDINGS 
This dissertation investigates one aspect of the developmental dynamics of dopamine in 
adolescent rats, compared to adults, in two functionally distinct and dopamine innervated striatal 
subregions, the NAc and the DS. Using the systemic administration of amphetamine to activate 
dopamine release in behaving rats, we demonstrated that adolescents are less sensitive to 
amphetamine-induced hyperlocomotion than adults. This is likely a result of lower levels of 
amphetamine-induced dopamine efflux in the DS, but not in the NAc, of adolescent rats 
compared to adults, since these behaviors are mediated by striatal dopamine. We demonstrated 
that the reduced effects of amphetamine in the DS were likely not due to developmental 
differences in the functional capacity of DAT. Though adults show greater expression of DAT 
protein in both NAc and DS tissue, there were no region-specific differences in DAT-mediated 
clearance of dopamine by age group. In both regions, blocking DAT with the inhibitor 
nomifensine produced similar levels of basal and amphetamine-induced dopamine efflux in 
adults and adolescents. We further showed that reduced amphetamine-induced dopamine in the 
DS of adolescent rats by amphetamine is likely due to region-specific reductions in TH levels in 
the DS. We also provided evidence that adolescent rats are more sensitive to the effects of a TH 
inhibitor when evaluating stereotypies, but not locomotion. Together, these data suggest that 
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dopamine neurotransmission in the DS of adolescents is hypofunctional compared to adults, and 
this is likely the result, in part, of reduced TH expression and activity. Further, this age-related 
difference is restricted to the dorsal subregion of the striatum, suggesting regional specificity in 
the development of the dopamine system.   
5.2 NEURAL MECHANISMS OF ADOLESCENT BEHAVIOR 
5.2.1 Neurobehavioral models of adolescence 
The striatum is essential in motor planning and decision making, and therefore the 
developmental remodeling of this region throughout adolescence is important to study. Previous 
models have implicated the limbic system, in particular the amygdala and the NAc, in the 
functional immaturities of the adolescent brain (Spear, 2000). For example, the triadic node 
model, a systems-based model of adolescent decision-making, asserts that neurodevelopment and 
function of the key regions involved in the control of motivated behavior (such as the amygdala, 
NAc, and medial-ventral prefrontal cortex) are underdeveloped, as well as the balance between 
these regions (Ernst et al., 2006). Ernst suggests that the risk-taking propensity of adolescents 
can be explained by a strong reward system (NAc), a weak harm-avoidant system (amygdala), 
and/or an ineﬃcient supervisory system (medial-ventral prefrontal cortex). Disruptions in the 
balance of this triadic system may contribute to the expression of psychopathology. Another 
neurobiological model of adolescence, proposed by Casey and colleagues, asserts that 
differences in the developmental trajectory of the limbic reward system (ventral striatum and the 
amygdala) relative to top-down control systems (prefrontal cortex) and their circuit connections 
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may account for the behavioral changes observed during adolescence, including impulsive 
choices and risky decision making (Casey et al., 2008). This model, therefore suggests that 
immature prefrontal function alone does not account for adolescent behavior, as children’s less 
developed prefrontal cortex and cognitive abilities do not look similar or worse than adolescents. 
In further support of Casey’s model, human imaging studies have shown that in emotionally 
salient situations, adolescent NAc activity was similar to adults, while  activity in the 
orbitofrontal cortex was more like that of children than of adults (Galvan et al., 2006; Galvan et 
al., 2007).  
As such, both of the aforementioned models embody the notion that there is an imbalance 
of neurodevelopmental maturity in cortical regions relative to subcortical regions during 
adolescence, where each of these regions are all still immature in childhood but all mature in 
adulthood (Somerville et al., 2010). The data presented in this dissertation, as well as  data from 
a recent electrophysiology study from our laboratory (Sturman and Moghaddam, 2012), are 
partially consistent with the interpretation of there being no differences in the NAc of 
adolescents as compared to adults. However, our findings implicate the reduced dopamine 
neurotransmission in the DS, a region that is involved critically in learning, habit formation and 
action selections (Jog et al., 1999; Yin et al., 2008), may be a potential source for adolescent 
behavioral differences and associated vulnerabilities.  
5.2.2 A proposed model for hypodopaminergia in the DS of adolescents  
As mentioned in Section 1.3, the DS is heavily innervated by dopamine neurons from the 
substantia nigra pars compacta, and dopamine signaling in the DS plays an important role in 
voluntary motor control, instrumental learning, and habitual behavior. In addition to 
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dopaminergic inputs, the DS is heavily innervated by the cortex. Cortical glutamatergic afferents 
that innervate the DS are predominantly from sensory-motor cortical areas, the anterior cingulate 
cortex, and prelimbic cortex (Groenewegen and Berendse, 1994; Voorn et al., 2004). Dopamine 
is involved in modulating striatal neurons primarily by modulating the impact of excitatory 
inputs onto these neurons (Wickens et al., 2007b; Surmeier et al., 2011). Several anatomical and 
functional studies have shown that dopamine directly regulates glutamate release from 
corticostriatal terminals by stimulating D2 receptors on a subset of non-dopaminergic cortical 
afferents, which serve as a mechanism for dampening critical cortical signals (Calabresi et al., 
1993; O'Donnell and Grace, 1994; Sesack et al., 1994; Hsu et al., 1995; Cepeda et al., 2001; 
West and Grace, 2002). Thus, reduced dopamine activity on corticostriatal afferents in the DS 
during adolescence may lead to enhanced function of the cortical input, particularly prefrontal 
input that mediates learning and habit formation. The differential cortical and midbrain influence 
over the DS compared to the NAc may contribute to differences in dopamine neurotransmission 
in these areas throughout adolescence, and may serve as a mechanism for increased vulnerability 
to dopamine related illnesses like schizophrenia and addiction. 
The findings in this dissertation may support the notion that the modulatory role of 
dopamine is reduced in the DS of adolescents. Therefore, we propose that the reduced levels of 
TH in the DS of adolescent rats compared to adults are due to weaker cortical input to the DS or 
DS-projecting dopamine cells in SNc (Figure 5-1). We suggest that these cortical inputs likely 
originate from the anterior cingulate cortex, due to its role in impulsivity, a behavior that is 
characteristic to adolescents. Though it should be noted that the DS receives input from areas 
other than the cortical regions, such as thalamic nuclei (Voorn et al., 2004), for simplicity we 
have only included the striatum, cortex, and midbrain structures in this model. We believe that 
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corticostriatal connections involving portions of the medial prefrontal cortex, in particular the 
anterior cingulate cortex, may be an important yet overlooked circuit involved in adolescent 
development and behavior. The anterior cingulate cortex has projections to the DS and SNc and 
has been implicated in inhibitory control and conflict resolution, disruption of which results in 
impulsivity (Volkow et al., 2004). Additionally, the anterior cingulate cortex has been shown to 
receive dopaminergic input from the substantia nigra pars compacta (Berger et al., 1991). We 
propose that projections from the anterior cingulate cortex are weaker, or less developed in 
adolescents compared to adults. In contrast, we suggest that cortical inputs from the infralimbic 
portion of the medial prefrontal cortex projecting to the NAc are mature and fully developed in 
adolescent rats and are similar to those corticostriatal connections of adults. There is little 
overlap between projections from these cortical areas to the dorsal and ventral striatum and 
therefore these cortical regions may be differentially innervating their striatal targets. It should 
also be noted that very little is known about the developmental trajectories of these connections 
between the cortex, striatum and midbrain. The anatomical and functional connectivity of these 
areas is understudied, and require further attention to gain a better understanding of how these 
circuits develop.  
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Figure 5-1 A model of hypodopaminergic neurotransmission in the adolescent DS 
A simplistic diagram of corticostriatal circuits and dopamine modulation in adolescents and adults. Dopamine 
neurotransmission in the DS (right hand side) of adolescents is hypofunctional compared to adults, likely due to the 
reduced levels of TH protein found in adolescent DS. Dopamine synthesis and availability is activity dependent, and 
TH activity may be influenced by cortical projections to the DS or the SNc, or both. The dashed lines indicate 
reduced activity or connectivity from ACC to the DS and/or SNc. In contrast, dopaminergic neurotransmission is 
similar in the NAc of adolescent and adult rats. This may be a result of adult-like cortical projections to the NAc and 
VTA during adolescence. Abbreviations: ACC, anterior cingulate cortex; DA, dopamine; DS, dorsal striatum; Glu, 
glutamate; IL, infralimbic cortex; NAc, nucleus accumbens; SNc, substantia nigra par compacta; VTA, ventral 
tegmental area. 
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Dopamine synthesis and availability is activity dependent, and therefore synthesis is 
determined by TH activity, which is regulated through gene expression (long term regulation) 
and through feedback inhibition by catecholamines, allosteric regulation, and phosphorylation 
(short term regulation) (Kumer and Vrana, 1996). It is unlikely that the reduced expression of 
TH in the DS of adolescents is due to maturing midbrain dopamine structures. Dopamine neuron 
migration to the midbrain and innervation of their targets has reached maturation before the start 
of adolescence, and these dopamine neurons have acquired adult morphology and functionality 
by the third postnatal week in rats (Voorn et al., 1988). However, firing rates of ventral 
tegmental area dopamine neurons have been shown to peak during late adolescence before 
decreasing over time into adulthood (McCutcheon and Marinelli, 2009), suggesting that there are 
other factors that influence and regulate dopamine discharge and availability in the adolescent 
striatum. Yet, there is no published work on dopamine firing in the substantia nigra throughout 
development. Further studies are necessary to establish basal midbrain dopamine neuron activity 
in adolescence, as well as characterizing adolescent midbrain dopamine neurons response to 
external stimuli and pharmacological manipulation. Also, it would be worth examining the 
molecular mechanisms that influence dopamine activity.  
To further understand the region specific differences in the DS of adolescent and adult 
rats, it is necessary to identify the neural mechanisms involved in adolescent neurodevelopment 
and associated vulnerabilities, as well as determine the functional connectivity of cortical and 
striatal regions. What are the mechanisms influencing reduced dopamine in the DS in response to 
amphetamine? Are prefrontal cortical regions regulating striatal function differently as a function 
of age? Is there immature corticostriatal connectivity involving the DS during adolescence, 
compared to more mature corticostriatal connectivity involving the NAc? Is this functional 
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immaturity correlated with impulsivity or risky decision making? As our lab has reported 
recently, there are neural processing differences in both the orbital frontal cortex as well as the 
DS of adolescent and adult rats during reward-related tasks (Sturman and Moghaddam, 2011b, 
2012). There may also be processing differences found in other prefrontal cortical structures. It 
would be beneficial to further examine corticostriatal interactions by using electrophysiology 
recordings in behaving adolescent and adult rats. For example, simultaneously recording from 
various areas in the prefrontal cortex and striatal subregions (further divided based on its dorsal-
ventral functional and connectivity gradient) would reveal whether there are age-related 
differences in functional connectivity between the anterior cingulate cortex and the DS, versus 
similarities between the infralimbic cortex and the NAc.  
5.2.3 The importance of the DS in models of adolescent vulnerabilities 
The data presented in this dissertation suggest that the DS is an important region involved in 
adolescent neurodevelopment, and may be regulated differently in adolescents versus adults. In 
contrast, our findings further support the notion that the NAc is similar in both adolescents and 
adults. Though our studies have directly implicated differences only in dopamine 
neurotransmission in the DS of adolescents, we have proposed (in Section 5.2.2) that cortical 
inputs to the DS may be less mature in adolescents than adults, whereas cortical inputs to the 
NAc are similar in both age groups. Therefore, this proposal may provide new insights for 
examining the role of dopamine in cortico-dorsal-striatal circuits in adolescents. Based on 
previous studies, it had been established that thalamo-cortico-striatal loops are modulated by 
dopamine afferents from the ventral tegmental area and substantia nigra pars compacta, and this 
is thought to promote the learning of action sequences, selecting relevant behavioral patterns 
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while inhibiting irrelevant ones, and performing motivated behavior (Graybiel et al., 1994; 
Packard and Knowlton, 2002; Graybiel, 2005; Costa, 2007). 
As mentioned previously, the DS, along with the NAc and various prefrontal cortical 
areas, are involved in extreme habit formation such as drug addiction (Everitt & Robbins 2005, 
Kalivas et al. 2005, Kalivas & Volkow 2005). In addition, dopamine function in the DS has been 
implicated in the pathophysiology of schizophrenia (Howes et al., 2012). This is important in the 
context of adolescent neural and behavioral changes, as late adolescence is a period of 
conversion to psychosis in individuals at high risk to develop schizophrenia (Hafner et al., 1994). 
In addition, adolescents are more prone to risk taking and drug addiction than adults (as reviewed 
in Section 1.1). Though the NAc has received close attention for its role in addiction, the DS is 
also thought to be important in the craving stage of addiction (Koob and Volkow, 2010). Studies 
have shown that the DS circuitry is involved in habitual compulsive cocaine use, where it was 
observed that there was an increase in dopamine release in the DS of prolonged cocaine-seeking, 
but not in the ventral striatum of adult rats (Ito et al., 2002). Disconnecting the NAc from the DS 
in rats self-administering cocaine also has been shown to result in decreased drug intake in 
animals with well-established compulsive use (Belin and Everitt, 2008).  Furthermore, dopamine 
and glutamate neurotransmission in the DS is involved in cue-context dependent craving 
(Volkow et al., 2006). Together, these studies identify the DS as a fundamental component of 
drug addiction. More studies are needed to identify differences in the DS of adolescent and adult 
rats in the context of both normal habit formation and habitual drug use. Currently, it is unknown 
whether adolescents are more prone to forming habits than adults, or if there are age-related 
functional differences in neural activity of regions involved in habit formation, impulsivity and 
risky behavior – namely the DS and associated prefrontal cortical areas.  
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5.3 CONCLUSIONS 
Though the proposed model above is a hypothesis for adolescent development, our data provides 
a platform to conduct future studies of functional connectivity of developing corticostriatal 
circuits. Our data suggest that under some circumstances dopamine neurotransmission in the DS 
of adolescents is hypofunctional compared to adults, and this reduced dopaminergic activity may 
be due to reduced dopamine synthesis via reduced TH, the function of which we hypothesize is 
modulated by cortical inputs. This notion is consistent with exaggerated responsiveness of 
adolescent DS neurons to salient events such as reward expectancy compared to adults, whereas 
NAc neurons responded similarly in adolescents and adults (Sturman and Moghaddam, 2012). 
Furthermore, these findings support the idea that developmental changes of the 
mesocorticolimbic and nigrostriatal dopamine systems may contribute to adolescent vulnerability 
to illness (Chambers et al., 2003; O'Donnell, 2011), but more specifically indicates that a locus 
of this dopaminergic involvement in adolescent vulnerability is the DS. As part of normal 
development, reduced DS dopamine activity may in turn reduce inhibitory modulation of DS 
neurons by dopamine and facilitate learning. The same mechanism also may contribute to 
increased vulnerability to habit formation, impulsive decision making, and development of 
cognitive and affective illnesses that are associated with dysregulated dopamine 
neurotransmission.  
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